NO321658B1 - 3-Azabicyklo[3.1.0]heksanderivater som opiatreceptorligander - Google Patents
3-Azabicyklo[3.1.0]heksanderivater som opiatreceptorligander Download PDFInfo
- Publication number
- NO321658B1 NO321658B1 NO20013148A NO20013148A NO321658B1 NO 321658 B1 NO321658 B1 NO 321658B1 NO 20013148 A NO20013148 A NO 20013148A NO 20013148 A NO20013148 A NO 20013148A NO 321658 B1 NO321658 B1 NO 321658B1
- Authority
- NO
- Norway
- Prior art keywords
- mmol
- formula
- azabicyclo
- methyl
- compound
- Prior art date
Links
- 108090000137 Opioid Receptors Proteins 0.000 title claims description 10
- 102000003840 Opioid Receptors Human genes 0.000 title claims description 10
- 239000003446 ligand Substances 0.000 title description 4
- 150000005228 3‐azabicyclo[3.1.0]hexanes Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims description 315
- 239000000203 mixture Substances 0.000 claims description 228
- 238000002360 preparation method Methods 0.000 claims description 188
- -1 NH 2 Chemical group 0.000 claims description 179
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 59
- 238000004519 manufacturing process Methods 0.000 claims description 56
- 229910052736 halogen Inorganic materials 0.000 claims description 41
- 150000002367 halogens Chemical class 0.000 claims description 41
- 238000000034 method Methods 0.000 claims description 41
- 238000006243 chemical reaction Methods 0.000 claims description 37
- 239000000126 substance Substances 0.000 claims description 27
- 125000000217 alkyl group Chemical group 0.000 claims description 18
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 16
- 125000001424 substituent group Chemical group 0.000 claims description 16
- 125000004432 carbon atom Chemical group C* 0.000 claims description 15
- 229910052739 hydrogen Inorganic materials 0.000 claims description 15
- 230000009467 reduction Effects 0.000 claims description 15
- 238000011282 treatment Methods 0.000 claims description 15
- 125000003118 aryl group Chemical group 0.000 claims description 13
- 239000000460 chlorine Substances 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 10
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 10
- 125000002883 imidazolyl group Chemical group 0.000 claims description 10
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 10
- 229910052799 carbon Inorganic materials 0.000 claims description 9
- 239000003638 chemical reducing agent Substances 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 9
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 9
- 229910052801 chlorine Inorganic materials 0.000 claims description 8
- 125000000524 functional group Chemical group 0.000 claims description 8
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 8
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 claims description 8
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 7
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 7
- 125000000623 heterocyclic group Chemical group 0.000 claims description 7
- 125000004076 pyridyl group Chemical group 0.000 claims description 7
- 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 claims description 6
- 125000004104 aryloxy group Chemical group 0.000 claims description 6
- 201000010099 disease Diseases 0.000 claims description 6
- 125000003037 imidazol-2-yl group Chemical group [H]N1C([*])=NC([H])=C1[H] 0.000 claims description 6
- 230000009466 transformation Effects 0.000 claims description 6
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 5
- 125000003545 alkoxy group Chemical group 0.000 claims description 5
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 5
- 229910052794 bromium Inorganic materials 0.000 claims description 5
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 5
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims description 4
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims description 4
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 4
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 claims description 4
- 229910052740 iodine Inorganic materials 0.000 claims description 4
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 claims description 4
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 4
- 239000007800 oxidant agent Substances 0.000 claims description 4
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims description 4
- 235000010288 sodium nitrite Nutrition 0.000 claims description 4
- 125000001544 thienyl group Chemical group 0.000 claims description 4
- 238000000844 transformation Methods 0.000 claims description 4
- 125000006625 (C3-C8) cycloalkyloxy group Chemical group 0.000 claims description 3
- 125000001376 1,2,4-triazolyl group Chemical group N1N=C(N=C1)* 0.000 claims description 3
- RILZRCJGXSFXNE-UHFFFAOYSA-N 2-[4-(trifluoromethoxy)phenyl]ethanol Chemical compound OCCC1=CC=C(OC(F)(F)F)C=C1 RILZRCJGXSFXNE-UHFFFAOYSA-N 0.000 claims description 3
- 125000004174 2-benzimidazolyl group Chemical group [H]N1C(*)=NC2=C([H])C([H])=C([H])C([H])=C12 0.000 claims description 3
- 229910021591 Copper(I) chloride Inorganic materials 0.000 claims description 3
- 125000004429 atom Chemical group 0.000 claims description 3
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims description 3
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 claims description 3
- OWFXIOWLTKNBAP-UHFFFAOYSA-N isoamyl nitrite Chemical compound CC(C)CCON=O OWFXIOWLTKNBAP-UHFFFAOYSA-N 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims description 2
- 125000001399 1,2,3-triazolyl group Chemical group N1N=NC(=C1)* 0.000 claims description 2
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 2
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims description 2
- 125000003342 alkenyl group Chemical group 0.000 claims description 2
- 125000000304 alkynyl group Chemical group 0.000 claims description 2
- MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 claims description 2
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims description 2
- 125000004603 benzisoxazolyl group Chemical group O1N=C(C2=C1C=CC=C2)* 0.000 claims description 2
- 125000002047 benzodioxolyl group Chemical group O1OC(C2=C1C=CC=C2)* 0.000 claims description 2
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims description 2
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims description 2
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims description 2
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 claims description 2
- 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 claims description 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 2
- 229910002091 carbon monoxide Inorganic materials 0.000 claims description 2
- 125000001070 dihydroindolyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 claims description 2
- 125000005553 heteroaryloxy group Chemical group 0.000 claims description 2
- 125000005844 heterocyclyloxy group Chemical group 0.000 claims description 2
- 125000002140 imidazol-4-yl group Chemical group [H]N1C([H])=NC([*])=C1[H] 0.000 claims description 2
- 125000001041 indolyl group Chemical group 0.000 claims description 2
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 claims description 2
- 125000000842 isoxazolyl group Chemical group 0.000 claims description 2
- 125000001624 naphthyl group Chemical group 0.000 claims description 2
- 125000005544 phthalimido group Chemical group 0.000 claims description 2
- 125000005545 phthalimidyl group Chemical group 0.000 claims description 2
- 238000006467 substitution reaction Methods 0.000 claims description 2
- 125000004434 sulfur atom Chemical group 0.000 claims description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N sulfur dioxide Inorganic materials O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 claims description 2
- 125000001712 tetrahydronaphthyl group Chemical group C1(CCCC2=CC=CC=C12)* 0.000 claims description 2
- 125000001425 triazolyl group Chemical group 0.000 claims description 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 3
- 229940126601 medicinal product Drugs 0.000 claims 2
- IISBACLAFKSPIT-UHFFFAOYSA-N bisphenol A Chemical compound C=1C=C(O)C=CC=1C(C)(C)C1=CC=C(O)C=C1 IISBACLAFKSPIT-UHFFFAOYSA-N 0.000 claims 1
- 125000004230 chromenyl group Chemical group O1C(C=CC2=CC=CC=C12)* 0.000 claims 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 552
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 486
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 322
- 239000000243 solution Substances 0.000 description 296
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 254
- 239000011541 reaction mixture Substances 0.000 description 214
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 212
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 204
- 238000005481 NMR spectroscopy Methods 0.000 description 186
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 164
- 235000019439 ethyl acetate Nutrition 0.000 description 157
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 145
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 144
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 142
- 239000003921 oil Substances 0.000 description 130
- 235000019198 oils Nutrition 0.000 description 130
- 239000000741 silica gel Substances 0.000 description 129
- 229910002027 silica gel Inorganic materials 0.000 description 129
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 122
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 121
- 239000000284 extract Substances 0.000 description 117
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 115
- 239000000047 product Substances 0.000 description 112
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 100
- 239000012458 free base Substances 0.000 description 89
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 88
- 235000017557 sodium bicarbonate Nutrition 0.000 description 80
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 80
- 239000010410 layer Substances 0.000 description 72
- 239000011734 sodium Substances 0.000 description 67
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 60
- 239000007787 solid Substances 0.000 description 60
- 239000012280 lithium aluminium hydride Substances 0.000 description 58
- 229910021529 ammonia Inorganic materials 0.000 description 57
- 239000012230 colorless oil Substances 0.000 description 56
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 51
- 238000004587 chromatography analysis Methods 0.000 description 51
- 229910052757 nitrogen Inorganic materials 0.000 description 50
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 49
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 48
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 45
- 238000010992 reflux Methods 0.000 description 45
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 44
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 41
- 235000011114 ammonium hydroxide Nutrition 0.000 description 41
- HNQIVZYLYMDVSB-UHFFFAOYSA-N methanesulfonimidic acid Chemical compound CS(N)(=O)=O HNQIVZYLYMDVSB-UHFFFAOYSA-N 0.000 description 35
- HXNFBHSHHRXNAR-UHFFFAOYSA-N n-[3-(6-methyl-3-azabicyclo[3.1.0]hexan-6-yl)phenyl]methanesulfonamide Chemical compound C12CNCC2C1(C)C1=CC=CC(NS(C)(=O)=O)=C1 HXNFBHSHHRXNAR-UHFFFAOYSA-N 0.000 description 33
- 238000003818 flash chromatography Methods 0.000 description 31
- 238000002953 preparative HPLC Methods 0.000 description 31
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 30
- 238000004440 column chromatography Methods 0.000 description 30
- 239000012299 nitrogen atmosphere Substances 0.000 description 30
- 239000002904 solvent Substances 0.000 description 27
- QQZOPKMRPOGIEB-UHFFFAOYSA-N 2-Oxohexane Chemical compound CCCCC(C)=O QQZOPKMRPOGIEB-UHFFFAOYSA-N 0.000 description 23
- 238000010898 silica gel chromatography Methods 0.000 description 23
- 238000001816 cooling Methods 0.000 description 22
- MIJHLFLLTSNFHU-UHFFFAOYSA-N 3-(3-hexyl-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl)aniline Chemical compound C1N(CCCCCC)CC2C1C2(C)C1=CC=CC(N)=C1 MIJHLFLLTSNFHU-UHFFFAOYSA-N 0.000 description 20
- 150000003839 salts Chemical class 0.000 description 20
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 18
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 18
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 18
- 239000012044 organic layer Substances 0.000 description 18
- 238000003756 stirring Methods 0.000 description 18
- 239000012043 crude product Substances 0.000 description 17
- 239000000706 filtrate Substances 0.000 description 16
- 241001465754 Metazoa Species 0.000 description 15
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 15
- 229920006395 saturated elastomer Polymers 0.000 description 15
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 14
- 229910000029 sodium carbonate Inorganic materials 0.000 description 14
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 12
- 238000001704 evaporation Methods 0.000 description 12
- 230000008020 evaporation Effects 0.000 description 12
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 12
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 12
- 208000003251 Pruritus Diseases 0.000 description 11
- 238000009472 formulation Methods 0.000 description 11
- 239000012071 phase Substances 0.000 description 11
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 10
- 239000002585 base Substances 0.000 description 10
- 238000001914 filtration Methods 0.000 description 10
- 239000012074 organic phase Substances 0.000 description 10
- 238000011176 pooling Methods 0.000 description 10
- 238000000825 ultraviolet detection Methods 0.000 description 10
- 159000000021 acetate salts Chemical class 0.000 description 9
- 239000012298 atmosphere Substances 0.000 description 9
- 239000000872 buffer Substances 0.000 description 9
- YVPJCJLMRRTDMQ-UHFFFAOYSA-N ethyl diazoacetate Chemical compound CCOC(=O)C=[N+]=[N-] YVPJCJLMRRTDMQ-UHFFFAOYSA-N 0.000 description 9
- 239000000543 intermediate Substances 0.000 description 9
- 125000006239 protecting group Chemical group 0.000 description 9
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 8
- 239000001257 hydrogen Substances 0.000 description 8
- INWIOXGUKUPWQZ-UHFFFAOYSA-N n-[3-[6-methyl-3-(3-phenylpropyl)-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C1C2C(C)(C=3C=C(NS(C)(=O)=O)C=CC=3)C2CN1CCCC1=CC=CC=C1 INWIOXGUKUPWQZ-UHFFFAOYSA-N 0.000 description 8
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 7
- 239000005695 Ammonium acetate Substances 0.000 description 7
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 7
- 235000019257 ammonium acetate Nutrition 0.000 description 7
- 229940043376 ammonium acetate Drugs 0.000 description 7
- 239000012267 brine Substances 0.000 description 7
- FRYHCSODNHYDPU-UHFFFAOYSA-N ethanesulfonyl chloride Chemical compound CCS(Cl)(=O)=O FRYHCSODNHYDPU-UHFFFAOYSA-N 0.000 description 7
- 239000011521 glass Substances 0.000 description 7
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 7
- 235000019341 magnesium sulphate Nutrition 0.000 description 7
- 238000002844 melting Methods 0.000 description 7
- 230000008018 melting Effects 0.000 description 7
- 239000002244 precipitate Substances 0.000 description 7
- VUPQHSHTKBZVML-UHFFFAOYSA-J rhodium(3+);tetraacetate Chemical compound [Rh+3].[Rh+3].CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O VUPQHSHTKBZVML-UHFFFAOYSA-J 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 6
- 239000007832 Na2SO4 Substances 0.000 description 6
- 239000007868 Raney catalyst Substances 0.000 description 6
- 229910000564 Raney nickel Inorganic materials 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 6
- 239000007983 Tris buffer Substances 0.000 description 6
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 6
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 6
- 229910052938 sodium sulfate Inorganic materials 0.000 description 6
- 235000011152 sodium sulphate Nutrition 0.000 description 6
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 5
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 5
- 239000008346 aqueous phase Substances 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzenecarbonitrile Natural products N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- OKKHRLSLAZHHLD-UHFFFAOYSA-N ethyl 3-(chloromethyl)-2-methyl-2-(3-nitrophenyl)cyclopropane-1-carboxylate Chemical compound CCOC(=O)C1C(CCl)C1(C)C1=CC=CC([N+]([O-])=O)=C1 OKKHRLSLAZHHLD-UHFFFAOYSA-N 0.000 description 5
- 239000006260 foam Substances 0.000 description 5
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-Butyllithium Substances [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- AEFFNRITZFJGNP-UHFFFAOYSA-N 3-[6-methyl-3-(3-phenylpropyl)-3-azabicyclo[3.1.0]hexan-6-yl]aniline Chemical compound C1C2C(C)(C=3C=C(N)C=CC=3)C2CN1CCCC1=CC=CC=C1 AEFFNRITZFJGNP-UHFFFAOYSA-N 0.000 description 4
- LYUQWQRTDLVQGA-UHFFFAOYSA-N 3-phenylpropylamine Chemical compound NCCCC1=CC=CC=C1 LYUQWQRTDLVQGA-UHFFFAOYSA-N 0.000 description 4
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 235000019502 Orange oil Nutrition 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine hydrate Chemical compound O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 4
- GLTHZFRKDOTZFB-UHFFFAOYSA-N n-[3-(3-hexyl-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl)phenyl]methanesulfonamide Chemical compound C1N(CCCCCC)CC2C1C2(C)C1=CC=CC(NS(C)(=O)=O)=C1 GLTHZFRKDOTZFB-UHFFFAOYSA-N 0.000 description 4
- 239000010502 orange oil Substances 0.000 description 4
- 229920000573 polyethylene Polymers 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 4
- 235000009518 sodium iodide Nutrition 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- GGUBFICZYGKNTD-UHFFFAOYSA-N triethyl phosphonoacetate Chemical compound CCOC(=O)CP(=O)(OCC)OCC GGUBFICZYGKNTD-UHFFFAOYSA-N 0.000 description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 4
- ONDSBJMLAHVLMI-UHFFFAOYSA-N trimethylsilyldiazomethane Chemical compound C[Si](C)(C)[CH-][N+]#N ONDSBJMLAHVLMI-UHFFFAOYSA-N 0.000 description 4
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
- DNIKGDOEFORLBL-VMPITWQZSA-N (e)-3-(3-nitrophenyl)but-2-en-1-ol Chemical compound OC\C=C(/C)C1=CC=CC([N+]([O-])=O)=C1 DNIKGDOEFORLBL-VMPITWQZSA-N 0.000 description 3
- BMVXCPBXGZKUPN-UHFFFAOYSA-N 1-hexanamine Chemical compound CCCCCCN BMVXCPBXGZKUPN-UHFFFAOYSA-N 0.000 description 3
- RAHGQUJLSNHWBM-UHFFFAOYSA-N 3-(3-hexyl-6-methyl-2-oxo-3-azabicyclo[3.1.0]hexan-6-yl)benzonitrile Chemical compound O=C1N(CCCCCC)CC2C1C2(C)C1=CC=CC(C#N)=C1 RAHGQUJLSNHWBM-UHFFFAOYSA-N 0.000 description 3
- CEGPPZVCJZVCJT-UHFFFAOYSA-N 4-(3-hexyl-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl)benzene-1,2-diamine Chemical compound C1N(CCCCCC)CC2C1C2(C)C1=CC=C(N)C(N)=C1 CEGPPZVCJZVCJT-UHFFFAOYSA-N 0.000 description 3
- ZLYBFBAHAQEEQQ-UHFFFAOYSA-N 4-chlorobenzenesulfonyl chloride Chemical compound ClC1=CC=C(S(Cl)(=O)=O)C=C1 ZLYBFBAHAQEEQQ-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 208000007848 Alcoholism Diseases 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010012434 Dermatitis allergic Diseases 0.000 description 3
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 3
- 208000030814 Eating disease Diseases 0.000 description 3
- 241000400611 Eucalyptus deanei Species 0.000 description 3
- 208000019454 Feeding and Eating disease Diseases 0.000 description 3
- 206010019196 Head injury Diseases 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- 206010028813 Nausea Diseases 0.000 description 3
- 208000012488 Opiate Overdose Diseases 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 201000001880 Sexual dysfunction Diseases 0.000 description 3
- 208000020339 Spinal injury Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- LXFQFQPMCBYNLM-UHFFFAOYSA-N [6-(3-aminophenyl)-3-hexyl-3-azabicyclo[3.1.0]hexan-6-yl]methanol Chemical compound C1N(CCCCCC)CC2C1C2(CO)C1=CC=CC(N)=C1 LXFQFQPMCBYNLM-UHFFFAOYSA-N 0.000 description 3
- 125000004423 acyloxy group Chemical group 0.000 description 3
- 201000008937 atopic dermatitis Diseases 0.000 description 3
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 3
- 239000001110 calcium chloride Substances 0.000 description 3
- 229910001628 calcium chloride Inorganic materials 0.000 description 3
- 235000011148 calcium chloride Nutrition 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- BJDCWCLMFKKGEE-CMDXXVQNSA-N chembl252518 Chemical compound C([C@@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2O[C@H](O)[C@@H]4C BJDCWCLMFKKGEE-CMDXXVQNSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 3
- 235000014632 disordered eating Nutrition 0.000 description 3
- OKGWFJRRFXWDSS-UHFFFAOYSA-N ethyl 2-[[3-(3-hexyl-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl)phenyl]sulfamoyl]acetate Chemical compound C1N(CCCCCC)CC2C1C2(C)C1=CC=CC(NS(=O)(=O)CC(=O)OCC)=C1 OKGWFJRRFXWDSS-UHFFFAOYSA-N 0.000 description 3
- MPFDWDWWGCYGSL-UHFFFAOYSA-N ethyl 3-(chloromethyl)-2-(3-cyanophenyl)-2-methylcyclopropane-1-carboxylate Chemical compound CCOC(=O)C1C(CCl)C1(C)C1=CC=CC(C#N)=C1 MPFDWDWWGCYGSL-UHFFFAOYSA-N 0.000 description 3
- PCOXHTBLJZBQKO-UHFFFAOYSA-N ethyl 3-(chloromethyl)-2-ethyl-2-(3-nitrophenyl)cyclopropane-1-carboxylate Chemical compound CCOC(=O)C1C(CCl)C1(CC)C1=CC=CC([N+]([O-])=O)=C1 PCOXHTBLJZBQKO-UHFFFAOYSA-N 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 208000002551 irritable bowel syndrome Diseases 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 3
- 230000008693 nausea Effects 0.000 description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 102000005962 receptors Human genes 0.000 description 3
- 108020003175 receptors Proteins 0.000 description 3
- 231100000872 sexual dysfunction Toxicity 0.000 description 3
- 230000035939 shock Effects 0.000 description 3
- 230000000391 smoking effect Effects 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical class CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- 125000004767 (C1-C4) haloalkoxy group Chemical group 0.000 description 2
- XVSCYKCCQSCPMP-VMPITWQZSA-N (e)-3-(3-cyanophenyl)but-2-enoic acid Chemical compound OC(=O)\C=C(/C)C1=CC=CC(C#N)=C1 XVSCYKCCQSCPMP-VMPITWQZSA-N 0.000 description 2
- DOYXRXMTMCVACB-DUXPYHPUSA-N (e)-3-(3-nitrophenyl)prop-2-en-1-ol Chemical compound OC\C=C\C1=CC=CC([N+]([O-])=O)=C1 DOYXRXMTMCVACB-DUXPYHPUSA-N 0.000 description 2
- SPEUIVXLLWOEMJ-UHFFFAOYSA-N 1,1-dimethoxyethane Chemical compound COC(C)OC SPEUIVXLLWOEMJ-UHFFFAOYSA-N 0.000 description 2
- NBYVHZCBQXBVFZ-UHFFFAOYSA-N 1-(1-adamantyl)-n-[(1-methylbenzimidazol-2-yl)methyl]ethanamine Chemical compound C1C(C2)CC(C3)CC2CC13C(C)NCC1=NC2=CC=CC=C2N1C NBYVHZCBQXBVFZ-UHFFFAOYSA-N 0.000 description 2
- WVCOXGRCYMPXEK-DUXPYHPUSA-N 1-[(e)-3-bromoprop-1-enyl]-3-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC(\C=C\CBr)=C1 WVCOXGRCYMPXEK-DUXPYHPUSA-N 0.000 description 2
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- DUNNNVSEUCJEOY-UHFFFAOYSA-N 2-methoxyethanesulfonyl chloride Chemical compound COCCS(Cl)(=O)=O DUNNNVSEUCJEOY-UHFFFAOYSA-N 0.000 description 2
- HDECRAPHCDXMIJ-UHFFFAOYSA-N 2-methylbenzenesulfonyl chloride Chemical compound CC1=CC=CC=C1S(Cl)(=O)=O HDECRAPHCDXMIJ-UHFFFAOYSA-N 0.000 description 2
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 2
- AIOPCFGLPCYHCC-UHFFFAOYSA-N 3-(3-benzyl-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl)aniline Chemical compound C1C2C(C)(C=3C=C(N)C=CC=3)C2CN1CC1=CC=CC=C1 AIOPCFGLPCYHCC-UHFFFAOYSA-N 0.000 description 2
- ROFRFPCHLLQGFG-UHFFFAOYSA-N 3-(6-ethyl-3-hexyl-3-azabicyclo[3.1.0]hexan-6-yl)aniline Chemical compound C1N(CCCCCC)CC2C1C2(CC)C1=CC=CC(N)=C1 ROFRFPCHLLQGFG-UHFFFAOYSA-N 0.000 description 2
- JWQVQZCIXCEJEY-WEVVVXLNSA-N 3-[(e)-4-chlorobut-2-en-2-yl]benzonitrile Chemical compound ClC\C=C(/C)C1=CC=CC(C#N)=C1 JWQVQZCIXCEJEY-WEVVVXLNSA-N 0.000 description 2
- WQKWYQAZZMUCQS-WEVVVXLNSA-N 3-[(e)-4-hydroxybut-2-en-2-yl]benzonitrile Chemical compound OC\C=C(/C)C1=CC=CC(C#N)=C1 WQKWYQAZZMUCQS-WEVVVXLNSA-N 0.000 description 2
- JNMORJBUMMDWSY-UHFFFAOYSA-N 3-[3-(3-cyclohexylpropyl)-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl]aniline Chemical compound C1C2C(C)(C=3C=C(N)C=CC=3)C2CN1CCCC1CCCCC1 JNMORJBUMMDWSY-UHFFFAOYSA-N 0.000 description 2
- ORPUYERHEJSLRM-UHFFFAOYSA-N 3-[6-ethyl-3-(3-phenylpropyl)-3-azabicyclo[3.1.0]hexan-6-yl]aniline Chemical compound C1C2C(CC)(C=3C=C(N)C=CC=3)C2CN1CCCC1=CC=CC=C1 ORPUYERHEJSLRM-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- CXFIWPAUNODACX-KQQUZDAGSA-N 4-[(1e,3e)-4-[4-(dimethylamino)phenyl]buta-1,3-dienyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1\C=C\C=C\C1=CC=C(N(C)C)C=C1 CXFIWPAUNODACX-KQQUZDAGSA-N 0.000 description 2
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 description 2
- GQCQMFYIFUDARF-UHFFFAOYSA-N 4-bromo-1,1,2-trifluorobut-1-ene Chemical compound FC(F)=C(F)CCBr GQCQMFYIFUDARF-UHFFFAOYSA-N 0.000 description 2
- YTSHWMHQSTZYDD-UHFFFAOYSA-N 5-(3-hexyl-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl)-2-nitroaniline Chemical compound C1N(CCCCCC)CC2C1C2(C)C1=CC=C([N+]([O-])=O)C(N)=C1 YTSHWMHQSTZYDD-UHFFFAOYSA-N 0.000 description 2
- 239000005660 Abamectin Substances 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 2
- 206010003645 Atopy Diseases 0.000 description 2
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 208000006877 Insect Bites and Stings Diseases 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 229910003204 NH2 Inorganic materials 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- 101100244562 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) oprD gene Proteins 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- ZZHLYYDVIOPZBE-UHFFFAOYSA-N Trimeprazine Chemical compound C1=CC=C2N(CC(CN(C)C)C)C3=CC=CC=C3SC2=C1 ZZHLYYDVIOPZBE-UHFFFAOYSA-N 0.000 description 2
- RUROFEVDCUGKHD-QPJJXVBHSA-N [(e)-3-bromoprop-1-enyl]benzene Chemical compound BrC\C=C\C1=CC=CC=C1 RUROFEVDCUGKHD-QPJJXVBHSA-N 0.000 description 2
- 150000001241 acetals Chemical class 0.000 description 2
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 2
- 239000012346 acetyl chloride Substances 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 125000005233 alkylalcohol group Chemical group 0.000 description 2
- 229940125715 antihistaminic agent Drugs 0.000 description 2
- 239000000739 antihistaminic agent Substances 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 210000005013 brain tissue Anatomy 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Substances ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 108700023159 delta Opioid Receptors Proteins 0.000 description 2
- 102000048124 delta Opioid Receptors Human genes 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- ZBAWVBSWRGWUPY-JXMROGBWSA-N ethyl (e)-3-(3-cyanophenyl)but-2-enoate Chemical compound CCOC(=O)\C=C(/C)C1=CC=CC(C#N)=C1 ZBAWVBSWRGWUPY-JXMROGBWSA-N 0.000 description 2
- YWGRWUCXXBYRFF-VQHVLOKHSA-N ethyl (e)-3-(3-nitrophenyl)but-2-enoate Chemical compound CCOC(=O)\C=C(/C)C1=CC=CC([N+]([O-])=O)=C1 YWGRWUCXXBYRFF-VQHVLOKHSA-N 0.000 description 2
- OILAZJYUFUDZAH-MDZDMXLPSA-N ethyl (e)-3-(3-nitrophenyl)pent-2-enoate Chemical compound CCOC(=O)\C=C(/CC)C1=CC=CC([N+]([O-])=O)=C1 OILAZJYUFUDZAH-MDZDMXLPSA-N 0.000 description 2
- WDRQOOUZYWXCEF-UHFFFAOYSA-N ethyl 2-(bromomethyl)-3-phenylcyclopropane-1-carboxylate Chemical compound CCOC(=O)C1C(CBr)C1C1=CC=CC=C1 WDRQOOUZYWXCEF-UHFFFAOYSA-N 0.000 description 2
- XZBIXDPGRMLSTC-UHFFFAOYSA-N formohydrazide Chemical compound NNC=O XZBIXDPGRMLSTC-UHFFFAOYSA-N 0.000 description 2
- 238000001640 fractional crystallisation Methods 0.000 description 2
- 125000001188 haloalkyl group Chemical group 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 125000001072 heteroaryl group Chemical group 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- WHIDHHUCCTYJKA-UHFFFAOYSA-N isoquinoline-5-sulfonyl chloride Chemical compound N1=CC=C2C(S(=O)(=O)Cl)=CC=CC2=C1 WHIDHHUCCTYJKA-UHFFFAOYSA-N 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 102000048260 kappa Opioid Receptors Human genes 0.000 description 2
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- MOYMATSCMHSJNR-UHFFFAOYSA-N n-[3-(3-hexyl-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl)phenyl]acetamide Chemical compound C1N(CCCCCC)CC2C1C2(C)C1=CC=CC(NC(C)=O)=C1 MOYMATSCMHSJNR-UHFFFAOYSA-N 0.000 description 2
- ZVLFZRINKVYPMV-UHFFFAOYSA-N n-[3-[6-methyl-3-(3-phenylpropyl)-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide;hydrochloride Chemical compound Cl.C1C2C(C)(C=3C=C(NS(C)(=O)=O)C=CC=3)C2CN1CCCC1=CC=CC=C1 ZVLFZRINKVYPMV-UHFFFAOYSA-N 0.000 description 2
- UVSOHUSOSGQILV-UHFFFAOYSA-N n-[5-(3-hexyl-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl)-2-nitrophenyl]acetamide Chemical compound C1N(CCCCCC)CC2C1C2(C)C1=CC=C([N+]([O-])=O)C(NC(C)=O)=C1 UVSOHUSOSGQILV-UHFFFAOYSA-N 0.000 description 2
- AGRDPCWQGGNEQL-UHFFFAOYSA-N n-propan-2-ylsulfamoyl chloride Chemical compound CC(C)NS(Cl)(=O)=O AGRDPCWQGGNEQL-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 125000004043 oxo group Chemical group O=* 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 239000011698 potassium fluoride Substances 0.000 description 2
- 235000003270 potassium fluoride Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- KPBSJEBFALFJTO-UHFFFAOYSA-N propane-1-sulfonyl chloride Chemical compound CCCS(Cl)(=O)=O KPBSJEBFALFJTO-UHFFFAOYSA-N 0.000 description 2
- 238000011321 prophylaxis Methods 0.000 description 2
- 230000001823 pruritic effect Effects 0.000 description 2
- 238000001525 receptor binding assay Methods 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 235000015096 spirit Nutrition 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 238000000967 suction filtration Methods 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 125000004665 trialkylsilyl group Chemical group 0.000 description 2
- 108020001588 κ-opioid receptors Proteins 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- CNZIQHGDUXRUJS-CIGIFLASSA-N (2R,3S,5E,9R)-5-(1-hydroxyethylidene)-8,8-dimethyl-7,16-diazapentacyclo[9.6.1.02,9.03,7.015,18]octadeca-1(17),11(18),12,14-tetraene-4,6-dione Chemical compound C\C(O)=C1\C(=O)[C@@H]2[C@@H]3[C@@H](Cc4cccc5[nH]cc3c45)C(C)(C)N2C1=O CNZIQHGDUXRUJS-CIGIFLASSA-N 0.000 description 1
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 1
- BRVBKJUTAFVWNS-UHFFFAOYSA-N (3-cyclohexyl-3-oxopropyl) 4-bromobenzenesulfonate Chemical compound C1=CC(Br)=CC=C1S(=O)(=O)OCCC(=O)C1CCCCC1 BRVBKJUTAFVWNS-UHFFFAOYSA-N 0.000 description 1
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 description 1
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 description 1
- HPZJMUBDEAMBFI-WTNAPCKOSA-N (D-Ala(2)-mephe(4)-gly-ol(5))enkephalin Chemical compound C([C@H](N)C(=O)N[C@H](C)C(=O)NCC(=O)N(C)[C@@H](CC=1C=CC=CC=1)C(=O)NCCO)C1=CC=C(O)C=C1 HPZJMUBDEAMBFI-WTNAPCKOSA-N 0.000 description 1
- GTTYFUNIYKJEMP-RMKNXTFCSA-N (e)-3-(3-nitrophenyl)pent-2-en-1-ol Chemical compound OC\C=C(/CC)C1=CC=CC([N+]([O-])=O)=C1 GTTYFUNIYKJEMP-RMKNXTFCSA-N 0.000 description 1
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 1
- BTQIRRHVAGQEHI-UHFFFAOYSA-N 1,1,1-trifluoro-n-[3-(3-hexyl-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl)phenyl]methanesulfonamide Chemical compound C1N(CCCCCC)CC2C1C2(C)C1=CC=CC(NS(=O)(=O)C(F)(F)F)=C1 BTQIRRHVAGQEHI-UHFFFAOYSA-N 0.000 description 1
- 125000001506 1,2,3-triazol-5-yl group Chemical group [H]N1N=NC([H])=C1[*] 0.000 description 1
- 125000001305 1,2,4-triazol-3-yl group Chemical group [H]N1N=C([*])N=C1[H] 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- JXSPKRUNMHMICQ-UHFFFAOYSA-N 1-(2-bromoethoxy)-4-fluorobenzene Chemical compound FC1=CC=C(OCCBr)C=C1 JXSPKRUNMHMICQ-UHFFFAOYSA-N 0.000 description 1
- ACDKPXVTMLYNEE-UHFFFAOYSA-N 1-(3-chloropropyl)-4-methoxybenzene Chemical compound COC1=CC=C(CCCCl)C=C1 ACDKPXVTMLYNEE-UHFFFAOYSA-N 0.000 description 1
- WIZUCFDDYZQUJN-UHFFFAOYSA-N 1-(3-iodopropyl)-2-methylbenzene Chemical compound CC1=CC=CC=C1CCCI WIZUCFDDYZQUJN-UHFFFAOYSA-N 0.000 description 1
- ARKIFHPFTHVKDT-UHFFFAOYSA-N 1-(3-nitrophenyl)ethanone Chemical compound CC(=O)C1=CC=CC([N+]([O-])=O)=C1 ARKIFHPFTHVKDT-UHFFFAOYSA-N 0.000 description 1
- VSPOTMOYDHRALZ-UHFFFAOYSA-N 1-(3-nitrophenyl)propan-1-one Chemical compound CCC(=O)C1=CC=CC([N+]([O-])=O)=C1 VSPOTMOYDHRALZ-UHFFFAOYSA-N 0.000 description 1
- BYANUEVGUMPRMT-UHFFFAOYSA-N 1-(4-fluorophenyl)sulfonyl-n-(3-phenylpropyl)piperidine-4-carboxamide Chemical compound C1=CC(F)=CC=C1S(=O)(=O)N1CCC(C(=O)NCCCC=2C=CC=CC=2)CC1 BYANUEVGUMPRMT-UHFFFAOYSA-N 0.000 description 1
- DUBCVXSYZVTCOC-UHFFFAOYSA-N 1-(chloromethyl)-4-ethylbenzene Chemical compound CCC1=CC=C(CCl)C=C1 DUBCVXSYZVTCOC-UHFFFAOYSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- MBQGVXWECGJZSQ-RMKNXTFCSA-N 1-[(e)-1-chloropent-2-en-3-yl]-3-nitrobenzene Chemical compound ClC\C=C(/CC)C1=CC=CC([N+]([O-])=O)=C1 MBQGVXWECGJZSQ-RMKNXTFCSA-N 0.000 description 1
- DAIHJGQOEQIQIR-VMPITWQZSA-N 1-[(e)-4-bromobut-2-en-2-yl]-3-nitrobenzene Chemical compound BrC\C=C(/C)C1=CC=CC([N+]([O-])=O)=C1 DAIHJGQOEQIQIR-VMPITWQZSA-N 0.000 description 1
- IWCMXKIPKGJSGO-VMPITWQZSA-N 1-[(e)-4-chlorobut-2-en-2-yl]-3-nitrobenzene Chemical compound ClC\C=C(/C)C1=CC=CC([N+]([O-])=O)=C1 IWCMXKIPKGJSGO-VMPITWQZSA-N 0.000 description 1
- XAOFMTDKQYEOES-UHFFFAOYSA-N 1-bromo-5-methylhexane Chemical compound CC(C)CCCCBr XAOFMTDKQYEOES-UHFFFAOYSA-N 0.000 description 1
- KXUGUWTUFUWYRS-UHFFFAOYSA-N 1-methylimidazole-4-sulfonyl chloride Chemical compound CN1C=NC(S(Cl)(=O)=O)=C1 KXUGUWTUFUWYRS-UHFFFAOYSA-N 0.000 description 1
- SIYWVPMYOGMRDW-UHFFFAOYSA-N 2,1,3-benzoxadiazole-4-sulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC2=NON=C12 SIYWVPMYOGMRDW-UHFFFAOYSA-N 0.000 description 1
- DZVBXXCKUOHEDB-UHFFFAOYSA-N 2,2,2-trifluoro-n-[3-(3-hexyl-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl)phenyl]ethanesulfonamide Chemical compound C1N(CCCCCC)CC2C1C2(C)C1=CC=CC(NS(=O)(=O)CC(F)(F)F)=C1 DZVBXXCKUOHEDB-UHFFFAOYSA-N 0.000 description 1
- CXCHEKCRJQRVNG-UHFFFAOYSA-N 2,2,2-trifluoroethanesulfonyl chloride Chemical compound FC(F)(F)CS(Cl)(=O)=O CXCHEKCRJQRVNG-UHFFFAOYSA-N 0.000 description 1
- QKWWDTYDYOFRJL-UHFFFAOYSA-N 2,2-dimethoxyethanamine Chemical compound COC(CN)OC QKWWDTYDYOFRJL-UHFFFAOYSA-N 0.000 description 1
- HCPVYBCAYPMANM-UHFFFAOYSA-N 2-(1,3-dioxoisoindol-2-yl)ethanesulfonyl chloride Chemical compound C1=CC=C2C(=O)N(CCS(=O)(=O)Cl)C(=O)C2=C1 HCPVYBCAYPMANM-UHFFFAOYSA-N 0.000 description 1
- ZOJJJVRLKLQJNV-UHFFFAOYSA-N 2-(2,2-dimethoxyethoxy)-1,1-dimethoxyethane Chemical compound COC(OC)COCC(OC)OC ZOJJJVRLKLQJNV-UHFFFAOYSA-N 0.000 description 1
- 125000003163 2-(2-naphthyl)ethyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(C([H])=C([H])C2=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- MITJLSURCWPHGU-UHFFFAOYSA-N 2-(3-bromopropyl)-1,3-dichlorobenzene Chemical compound ClC1=CC=CC(Cl)=C1CCCBr MITJLSURCWPHGU-UHFFFAOYSA-N 0.000 description 1
- MRCIOZAROOFAEK-UHFFFAOYSA-N 2-(3-hexyl-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl)aniline Chemical compound C1N(CCCCCC)CC2C1C2(C)C1=CC=CC=C1N MRCIOZAROOFAEK-UHFFFAOYSA-N 0.000 description 1
- 125000006516 2-(benzyloxy)ethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- VHVPQPYKVGDNFY-DFMJLFEVSA-N 2-[(2r)-butan-2-yl]-4-[4-[4-[4-[[(2r,4s)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one Chemical compound O=C1N([C@H](C)CC)N=CN1C1=CC=C(N2CCN(CC2)C=2C=CC(OC[C@@H]3O[C@](CN4N=CN=C4)(OC3)C=3C(=CC(Cl)=CC=3)Cl)=CC=2)C=C1 VHVPQPYKVGDNFY-DFMJLFEVSA-N 0.000 description 1
- AYTXUKAAABIYJU-UHFFFAOYSA-N 2-[3-(3-hexyl-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl)phenyl]-1h-benzimidazole Chemical compound C1=CC=C2NC(C=3C=CC=C(C=3)C3(C)C4C3CN(C4)CCCCCC)=NC2=C1 AYTXUKAAABIYJU-UHFFFAOYSA-N 0.000 description 1
- ZXWFTUPJHKAEHY-UHFFFAOYSA-N 2-[4-(bromomethyl)phenyl]acetonitrile Chemical compound BrCC1=CC=C(CC#N)C=C1 ZXWFTUPJHKAEHY-UHFFFAOYSA-N 0.000 description 1
- HXEURDRGGNKAJL-UHFFFAOYSA-N 2-[4-(methanesulfonamido)phenyl]ethyl methanesulfonate Chemical compound CS(=O)(=O)NC1=CC=C(CCOS(C)(=O)=O)C=C1 HXEURDRGGNKAJL-UHFFFAOYSA-N 0.000 description 1
- MCSPMWOXBOZVJH-UHFFFAOYSA-N 2-[[3-(3-hexyl-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl)phenyl]sulfamoyl]acetamide Chemical compound C1N(CCCCCC)CC2C1C2(C)C1=CC=CC(NS(=O)(=O)CC(N)=O)=C1 MCSPMWOXBOZVJH-UHFFFAOYSA-N 0.000 description 1
- LYIIBVSRGJSHAV-UHFFFAOYSA-N 2-aminoacetaldehyde Chemical compound NCC=O LYIIBVSRGJSHAV-UHFFFAOYSA-N 0.000 description 1
- SPCKHVPPRJWQRZ-UHFFFAOYSA-N 2-benzhydryloxy-n,n-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 SPCKHVPPRJWQRZ-UHFFFAOYSA-N 0.000 description 1
- XSJYYBPRWGTEKK-UHFFFAOYSA-N 2-chloro-n-[3-(3-hexyl-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl)phenyl]benzenesulfonamide Chemical compound C1N(CCCCCC)CC2C1C2(C)C(C=1)=CC=CC=1NS(=O)(=O)C1=CC=CC=C1Cl XSJYYBPRWGTEKK-UHFFFAOYSA-N 0.000 description 1
- RLFIWYGMZQJEFO-UHFFFAOYSA-N 2-chloro-n-cyclohexylacetamide Chemical compound ClCC(=O)NC1CCCCC1 RLFIWYGMZQJEFO-UHFFFAOYSA-N 0.000 description 1
- KMVZDSQHLDGKGV-UHFFFAOYSA-N 2-chlorobenzenesulfonyl chloride Chemical compound ClC1=CC=CC=C1S(Cl)(=O)=O KMVZDSQHLDGKGV-UHFFFAOYSA-N 0.000 description 1
- WNNSWSZAPMCNIQ-UHFFFAOYSA-N 2-iodoethoxycyclohexane Chemical compound ICCOC1CCCCC1 WNNSWSZAPMCNIQ-UHFFFAOYSA-N 0.000 description 1
- NYACRWGQRUIHSO-UHFFFAOYSA-N 2-iodoethoxymethylbenzene Chemical compound ICCOCC1=CC=CC=C1 NYACRWGQRUIHSO-UHFFFAOYSA-N 0.000 description 1
- GSLTVFIVJMCNBH-UHFFFAOYSA-N 2-isocyanatopropane Chemical compound CC(C)N=C=O GSLTVFIVJMCNBH-UHFFFAOYSA-N 0.000 description 1
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 description 1
- VECOGDZPSCQNII-UHFFFAOYSA-N 3,5-dimethyl-2h-1,2-oxazole-3-sulfonyl chloride Chemical compound CC1=CC(C)(S(Cl)(=O)=O)NO1 VECOGDZPSCQNII-UHFFFAOYSA-N 0.000 description 1
- WMBYMLRPDYPRBE-UHFFFAOYSA-N 3-(3-cyclohexylpropyl)-6-methyl-6-(3-nitrophenyl)-3-azabicyclo[3.1.0]hexan-2-one Chemical compound O=C1C2C(C)(C=3C=C(C=CC=3)[N+]([O-])=O)C2CN1CCCC1CCCCC1 WMBYMLRPDYPRBE-UHFFFAOYSA-N 0.000 description 1
- ZMBXICXOXXXFHB-UHFFFAOYSA-N 3-(3-hexyl-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl)phenol Chemical compound C1N(CCCCCC)CC2C1C2(C)C1=CC=CC(O)=C1 ZMBXICXOXXXFHB-UHFFFAOYSA-N 0.000 description 1
- HEITYXMRMZWWPA-UHFFFAOYSA-N 3-(3-hexyl-6-propan-2-yl-3-azabicyclo[3.1.0]hexan-6-yl)aniline Chemical compound C1N(CCCCCC)CC2C1C2(C(C)C)C1=CC=CC(N)=C1 HEITYXMRMZWWPA-UHFFFAOYSA-N 0.000 description 1
- POYQSPPDCCSTKZ-UHFFFAOYSA-N 3-(3-hexyl-6-propyl-3-azabicyclo[3.1.0]hexan-6-yl)aniline Chemical compound C1N(CCCCCC)CC2C1C2(CCC)C1=CC=CC(N)=C1 POYQSPPDCCSTKZ-UHFFFAOYSA-N 0.000 description 1
- BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 1
- KHCZTKCJCDDBPN-UHFFFAOYSA-N 3-(6-methyl-3-prop-2-enyl-3-azabicyclo[3.1.0]hexan-6-yl)aniline Chemical compound C12CN(CC=C)CC2C1(C)C1=CC=CC(N)=C1 KHCZTKCJCDDBPN-UHFFFAOYSA-N 0.000 description 1
- RQFUZUMFPRMVDX-UHFFFAOYSA-N 3-Bromo-1-propanol Chemical compound OCCCBr RQFUZUMFPRMVDX-UHFFFAOYSA-N 0.000 description 1
- SNTQXLVTEFJPCX-UHFFFAOYSA-N 3-[3-(3-phenylpropyl)-3-azabicyclo[3.1.0]hexan-6-yl]aniline Chemical compound NC1=CC=CC(C2C3CN(CCCC=4C=CC=CC=4)CC32)=C1 SNTQXLVTEFJPCX-UHFFFAOYSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- NELDRPQGFKHXRQ-UHFFFAOYSA-N 3-[6-methyl-2-oxo-3-(3-phenylpropyl)-3-azabicyclo[3.1.0]hexan-6-yl]benzonitrile Chemical compound O=C1C2C(C)(C=3C=C(C=CC=3)C#N)C2CN1CCCC1=CC=CC=C1 NELDRPQGFKHXRQ-UHFFFAOYSA-N 0.000 description 1
- SBCFGFDAZCTSRH-UHFFFAOYSA-N 3-acetylbenzonitrile Chemical compound CC(=O)C1=CC=CC(C#N)=C1 SBCFGFDAZCTSRH-UHFFFAOYSA-N 0.000 description 1
- BJEPKHHBXQENQC-UHFFFAOYSA-N 3-benzyl-6-methyl-6-(3-nitrophenyl)-3-azabicyclo[3.1.0]hexan-2-one Chemical compound O=C1C2C(C)(C=3C=C(C=CC=3)[N+]([O-])=O)C2CN1CC1=CC=CC=C1 BJEPKHHBXQENQC-UHFFFAOYSA-N 0.000 description 1
- VAACVDBKKLTLQU-UHFFFAOYSA-N 3-benzyl-6-methyl-6-pyridin-3-yl-3-azabicyclo[3.1.0]hexane-2,4-dione Chemical compound C=1C=CN=CC=1C1(C)C(C2=O)C1C(=O)N2CC1=CC=CC=C1 VAACVDBKKLTLQU-UHFFFAOYSA-N 0.000 description 1
- RKNCIBMWPVZEAJ-UHFFFAOYSA-N 3-bromoprop-1-ynylbenzene Chemical compound BrCC#CC1=CC=CC=C1 RKNCIBMWPVZEAJ-UHFFFAOYSA-N 0.000 description 1
- NIDWUZTTXGJFNN-UHFFFAOYSA-N 3-bromopropoxybenzene Chemical compound BrCCCOC1=CC=CC=C1 NIDWUZTTXGJFNN-UHFFFAOYSA-N 0.000 description 1
- KPOYTMZDCUXJBP-UHFFFAOYSA-N 3-cyclohexylpropan-1-amine Chemical compound NCCCC1CCCCC1 KPOYTMZDCUXJBP-UHFFFAOYSA-N 0.000 description 1
- MYFUREAPMYGMRE-UHFFFAOYSA-N 3-hexyl-6-(3-hydroxyphenyl)-6-methyl-3-azabicyclo[3.1.0]hexan-2-one Chemical compound O=C1N(CCCCCC)CC2C1C2(C)C1=CC=CC(O)=C1 MYFUREAPMYGMRE-UHFFFAOYSA-N 0.000 description 1
- FLPKKMOAMXIRQE-UHFFFAOYSA-N 3-hexyl-6-[3-(1h-imidazol-2-yl)phenyl]-6-methyl-3-azabicyclo[3.1.0]hexan-2-one Chemical compound O=C1N(CCCCCC)CC2C1C2(C)C(C=1)=CC=CC=1C1=NC=CN1 FLPKKMOAMXIRQE-UHFFFAOYSA-N 0.000 description 1
- PJUIHJHULRHDPQ-UHFFFAOYSA-N 3-hexyl-6-[3-(1h-imidazol-2-yl)phenyl]-6-methyl-3-azabicyclo[3.1.0]hexane Chemical compound C1N(CCCCCC)CC2C1C2(C)C(C=1)=CC=CC=1C1=NC=CN1 PJUIHJHULRHDPQ-UHFFFAOYSA-N 0.000 description 1
- XUZRMBCUTMJBIP-UHFFFAOYSA-N 3-hexyl-6-[3-(1h-imidazol-5-yl)phenyl]-6-methyl-3-azabicyclo[3.1.0]hexan-2-one Chemical compound O=C1N(CCCCCC)CC2C1C2(C)C(C=1)=CC=CC=1C1=CN=CN1 XUZRMBCUTMJBIP-UHFFFAOYSA-N 0.000 description 1
- YFUMXLIFFABSIA-UHFFFAOYSA-N 3-hexyl-6-methyl-6-(3-nitrophenyl)-3-azabicyclo[3.1.0]hexan-2-one Chemical compound O=C1N(CCCCCC)CC2C1C2(C)C1=CC=CC([N+]([O-])=O)=C1 YFUMXLIFFABSIA-UHFFFAOYSA-N 0.000 description 1
- FKDRFJYFOWXTGV-UHFFFAOYSA-N 3-hexyl-6-methyl-6-(3-pyridin-2-ylphenyl)-3-azabicyclo[3.1.0]hexan-2-one Chemical compound O=C1N(CCCCCC)CC2C1C2(C)C(C=1)=CC=CC=1C1=CC=CC=N1 FKDRFJYFOWXTGV-UHFFFAOYSA-N 0.000 description 1
- QUADCHMDZSPJHB-UHFFFAOYSA-N 3-hexyl-6-methyl-6-(3-thiophen-2-ylphenyl)-3-azabicyclo[3.1.0]hexan-2-one Chemical compound O=C1N(CCCCCC)CC2C1C2(C)C(C=1)=CC=CC=1C1=CC=CS1 QUADCHMDZSPJHB-UHFFFAOYSA-N 0.000 description 1
- NCZOLSCCDRNMRW-UHFFFAOYSA-N 3-hexyl-6-methyl-6-[3-(1h-1,2,4-triazol-5-yl)phenyl]-3-azabicyclo[3.1.0]hexan-2-one Chemical compound O=C1N(CCCCCC)CC2C1C2(C)C(C=1)=CC=CC=1C1=NN=CN1 NCZOLSCCDRNMRW-UHFFFAOYSA-N 0.000 description 1
- VCEDHCKRUVEJHO-UHFFFAOYSA-N 3-hexyl-6-methyl-6-[3-(2h-triazol-4-yl)phenyl]-3-azabicyclo[3.1.0]hexan-2-one Chemical compound O=C1N(CCCCCC)CC2C1C2(C)C(C=1)=CC=CC=1C1=CNN=N1 VCEDHCKRUVEJHO-UHFFFAOYSA-N 0.000 description 1
- IYRGHMDUFKUYFK-UHFFFAOYSA-N 3-hexyl-6-methyl-6-[3-(5-trimethylsilyl-2h-triazol-4-yl)phenyl]-3-azabicyclo[3.1.0]hexan-2-one Chemical compound O=C1N(CCCCCC)CC2C1C2(C)C(C=1)=CC=CC=1C=1N=NNC=1[Si](C)(C)C IYRGHMDUFKUYFK-UHFFFAOYSA-N 0.000 description 1
- SLNRXMQYXWGJRX-UHFFFAOYSA-N 3-hexyl-6-methyl-6-[3-(sulfamoylamino)phenyl]-3-azabicyclo[3.1.0]hexane Chemical compound C1N(CCCCCC)CC2C1C2(C)C1=CC=CC(NS(N)(=O)=O)=C1 SLNRXMQYXWGJRX-UHFFFAOYSA-N 0.000 description 1
- DXVGZWKTLUOBGK-UHFFFAOYSA-N 3-hexyl-6-methyl-6-pyridin-3-yl-3-azabicyclo[3.1.0]hexane-2,4-dione Chemical compound O=C1N(CCCCCC)C(=O)C2C1C2(C)C1=CC=CN=C1 DXVGZWKTLUOBGK-UHFFFAOYSA-N 0.000 description 1
- NQWJKLQJXNRPPC-UHFFFAOYSA-N 3-hexyl-6-phenyl-3-azabicyclo[3.1.0]hexan-2-one Chemical compound O=C1N(CCCCCC)CC2C1C2C1=CC=CC=C1 NQWJKLQJXNRPPC-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- ZOCSXAVNDGMNBV-UHFFFAOYSA-N 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile Chemical compound NC1=C(S(=O)C(F)(F)F)C(C#N)=NN1C1=C(Cl)C=C(C(F)(F)F)C=C1Cl ZOCSXAVNDGMNBV-UHFFFAOYSA-N 0.000 description 1
- QRDSDKAGXMWBID-UHFFFAOYSA-N 5-azabicyclo[3.1.0]hexane Chemical compound C1CCN2CC21 QRDSDKAGXMWBID-UHFFFAOYSA-N 0.000 description 1
- IBSREHMXUMOFBB-JFUDTMANSA-N 5u8924t11h Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C(C)C)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 IBSREHMXUMOFBB-JFUDTMANSA-N 0.000 description 1
- NLNSONUDZISBON-UHFFFAOYSA-N 6-(3-aminophenyl)-3-benzyl-6-methyl-3-azabicyclo[3.1.0]hexan-2-one Chemical compound O=C1C2C(C)(C=3C=C(N)C=CC=3)C2CN1CC1=CC=CC=C1 NLNSONUDZISBON-UHFFFAOYSA-N 0.000 description 1
- CDSOJPQEWWXQKR-UHFFFAOYSA-N 6-(3-aminophenyl)-3-hexyl-3-azabicyclo[3.1.0]hexane-6-carbonitrile Chemical compound C1N(CCCCCC)CC2C1C2(C#N)C1=CC=CC(N)=C1 CDSOJPQEWWXQKR-UHFFFAOYSA-N 0.000 description 1
- ZAJYTQUSTZRMGP-UHFFFAOYSA-N 6-(3-hexyl-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl)-1h-benzimidazole Chemical compound C1=C2NC=NC2=CC(C2(C)C3C2CN(C3)CCCCCC)=C1 ZAJYTQUSTZRMGP-UHFFFAOYSA-N 0.000 description 1
- TUYSRPVIGCKKEZ-UHFFFAOYSA-N 6-(3-hexyl-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl)-2-(trifluoromethyl)-1h-benzimidazole Chemical compound C1=C2NC(C(F)(F)F)=NC2=CC(C2(C)C3C2CN(C3)CCCCCC)=C1 TUYSRPVIGCKKEZ-UHFFFAOYSA-N 0.000 description 1
- STSYQSCHVPIYLM-UHFFFAOYSA-N 6-(3-iodophenyl)-6-methyl-3-(3-phenylpropyl)-3-azabicyclo[3.1.0]hexane Chemical compound C1C2C(C)(C=3C=C(I)C=CC=3)C2CN1CCCC1=CC=CC=C1 STSYQSCHVPIYLM-UHFFFAOYSA-N 0.000 description 1
- JAFZUGPBBUEJQC-UHFFFAOYSA-N 6-(3-nitrophenyl)-3-(3-phenylpropyl)-3-azabicyclo[3.1.0]hexan-2-one Chemical compound [O-][N+](=O)C1=CC=CC(C2C3C(=O)N(CCCC=4C=CC=CC=4)CC32)=C1 JAFZUGPBBUEJQC-UHFFFAOYSA-N 0.000 description 1
- KCBWAFJCKVKYHO-UHFFFAOYSA-N 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine Chemical compound C1(CC1)C1=NC=NC(=C1C1=NC=C2C(=N1)N(N=C2)CC1=CC=C(C=C1)C=1N(C=C(N=1)C(F)(F)F)C(C)C)OC KCBWAFJCKVKYHO-UHFFFAOYSA-N 0.000 description 1
- VJIKPDDLZMDLMN-UHFFFAOYSA-N 6-[3-(1h-benzimidazol-2-yl)phenyl]-3-hexyl-6-methyl-3-azabicyclo[3.1.0]hexan-2-one Chemical compound C1=CC=C2NC(C=3C=CC=C(C=3)C3(C)C4C3CN(C4=O)CCCCCC)=NC2=C1 VJIKPDDLZMDLMN-UHFFFAOYSA-N 0.000 description 1
- RIMXEJYJXDBLIE-UHFFFAOYSA-N 6-bromohex-1-ene Chemical compound BrCCCCC=C RIMXEJYJXDBLIE-UHFFFAOYSA-N 0.000 description 1
- PHOSWLARCIBBJZ-UHFFFAOYSA-N 6-bromohexanenitrile Chemical compound BrCCCCCC#N PHOSWLARCIBBJZ-UHFFFAOYSA-N 0.000 description 1
- YMXVMKFIPGOSBW-UHFFFAOYSA-N 6-ethyl-3-hexyl-6-(3-nitrophenyl)-3-azabicyclo[3.1.0]hexan-2-one Chemical compound O=C1N(CCCCCC)CC2C1C2(CC)C1=CC=CC([N+]([O-])=O)=C1 YMXVMKFIPGOSBW-UHFFFAOYSA-N 0.000 description 1
- RDDZXEGIZIKCBR-UHFFFAOYSA-N 6-ethyl-6-(3-nitrophenyl)-3-(3-phenylpropyl)-3-azabicyclo[3.1.0]hexan-2-one Chemical compound O=C1C2C(CC)(C=3C=C(C=CC=3)[N+]([O-])=O)C2CN1CCCC1=CC=CC=C1 RDDZXEGIZIKCBR-UHFFFAOYSA-N 0.000 description 1
- NYANMZALGPEQCO-UHFFFAOYSA-N 6-methyl-3-(3-phenylpropyl)-6-[3-(2h-triazol-4-yl)phenyl]-3-azabicyclo[3.1.0]hexan-2-one Chemical compound O=C1C2C(C)(C=3C=C(C=CC=3)C=3NN=NC=3)C2CN1CCCC1=CC=CC=C1 NYANMZALGPEQCO-UHFFFAOYSA-N 0.000 description 1
- SENAUPCVKSGKFD-UHFFFAOYSA-N 6-methyl-3-(3-phenylpropyl)-6-[3-(5-trimethylsilyl-2h-triazol-4-yl)phenyl]-3-azabicyclo[3.1.0]hexan-2-one Chemical compound O=C1C2C(C)(C=3C=C(C=CC=3)C3=C(NN=N3)[Si](C)(C)C)C2CN1CCCC1=CC=CC=C1 SENAUPCVKSGKFD-UHFFFAOYSA-N 0.000 description 1
- PQCDAHIVSPALDL-UHFFFAOYSA-N 6-methyl-3-(3-phenylpropyl)-6-pyridin-3-yl-3-azabicyclo[3.1.0]hexane-2,4-dione Chemical compound C=1C=CN=CC=1C1(C)C(C2=O)C1C(=O)N2CCCC1=CC=CC=C1 PQCDAHIVSPALDL-UHFFFAOYSA-N 0.000 description 1
- LRZDGRFPZINDRX-UHFFFAOYSA-N 6-methyl-6-(3-nitrophenyl)-3-(3-phenylpropyl)-3-azabicyclo[3.1.0]hexan-2-one Chemical compound O=C1C2C(C)(C=3C=C(C=CC=3)[N+]([O-])=O)C2CN1CCCC1=CC=CC=C1 LRZDGRFPZINDRX-UHFFFAOYSA-N 0.000 description 1
- WIXNXMTXDQVCMN-UHFFFAOYSA-N 6-methyl-6-(3-nitrophenyl)-3-(3-phenylpropyl)-5-azabicyclo[3.1.0]hexane-2,4-dione Chemical compound C=1C=CC([N+]([O-])=O)=CC=1C1(C)C(C2=O)N1C(=O)C2CCCC1=CC=CC=C1 WIXNXMTXDQVCMN-UHFFFAOYSA-N 0.000 description 1
- BMSWRDNOCKSNQG-UHFFFAOYSA-N 6-methyl-6-(3-nitrophenyl)-3-prop-2-enyl-3-azabicyclo[3.1.0]hexan-2-one Chemical compound C12CN(CC=C)C(=O)C2C1(C)C1=CC=CC([N+]([O-])=O)=C1 BMSWRDNOCKSNQG-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 description 1
- 108700022183 Ala(2)-MePhe(4)-Gly(5)- Enkephalin Proteins 0.000 description 1
- APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 1
- 206010003399 Arthropod bite Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- SPFYMRJSYKOXGV-UHFFFAOYSA-N Baytril Chemical compound C1CN(CC)CCN1C(C(=C1)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1CC1 SPFYMRJSYKOXGV-UHFFFAOYSA-N 0.000 description 1
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 description 1
- 238000006418 Brown reaction Methods 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241001480079 Corymbia calophylla Species 0.000 description 1
- 108700022182 D-Penicillamine (2,5)- Enkephalin Proteins 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- MCMMCRYPQBNCPH-WMIMKTLMSA-N DPDPE Chemical compound C([C@H](N)C(=O)N[C@@H]1C(C)(C)SSC([C@@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)CNC1=O)C(O)=O)(C)C)C1=CC=C(O)C=C1 MCMMCRYPQBNCPH-WMIMKTLMSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 1
- IIUZTXTZRGLYTI-UHFFFAOYSA-N Dihydrogriseofulvin Natural products COC1CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 IIUZTXTZRGLYTI-UHFFFAOYSA-N 0.000 description 1
- 108010092674 Enkephalins Proteins 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 244000166102 Eucalyptus leucoxylon Species 0.000 description 1
- 235000004694 Eucalyptus leucoxylon Nutrition 0.000 description 1
- 240000001414 Eucalyptus viminalis Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 239000005899 Fipronil Substances 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- UXWOXTQWVMFRSE-UHFFFAOYSA-N Griseoviridin Natural products O=C1OC(C)CC=C(C(NCC=CC=CC(O)CC(O)C2)=O)SCC1NC(=O)C1=COC2=N1 UXWOXTQWVMFRSE-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000005906 Imidacloprid Substances 0.000 description 1
- BPFYOAJNDMUVBL-UHFFFAOYSA-N LSM-5799 Chemical compound C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3N(C)COC1=C32 BPFYOAJNDMUVBL-UHFFFAOYSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- URLZCHNOLZSCCA-VABKMULXSA-N Leu-enkephalin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 URLZCHNOLZSCCA-VABKMULXSA-N 0.000 description 1
- 229910010084 LiAlH4 Inorganic materials 0.000 description 1
- 235000006552 Liquidambar styraciflua Nutrition 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 239000012448 Lithium borohydride Substances 0.000 description 1
- 239000005912 Lufenuron Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- SIQGKPGBLYKQBB-UHFFFAOYSA-N N-(2,4,6-trimethylphenyl)-3-bicyclo[2.2.1]heptanecarboxamide Chemical compound CC1=CC(C)=CC(C)=C1NC(=O)C1C(C2)CCC2C1 SIQGKPGBLYKQBB-UHFFFAOYSA-N 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- DDUHZTYCFQRHIY-UHFFFAOYSA-N Negwer: 6874 Natural products COC1=CC(=O)CC(C)C11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-UHFFFAOYSA-N 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 241000238711 Pyroglyphidae Species 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 238000007239 Wittig reaction Methods 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 1
- RSKQVELBSOMXHS-HNNXBMFYSA-N [(3s)-3-cyclohexyl-3-hydroxypropyl] 4-bromobenzenesulfonate Chemical compound C([C@H](O)C1CCCCC1)COS(=O)(=O)C1=CC=C(Br)C=C1 RSKQVELBSOMXHS-HNNXBMFYSA-N 0.000 description 1
- ZUSWDTWYONAOPH-UHFFFAOYSA-N [2-(trifluoromethyl)phenyl]hydrazine;hydrochloride Chemical group [Cl-].[NH3+]NC1=CC=CC=C1C(F)(F)F ZUSWDTWYONAOPH-UHFFFAOYSA-N 0.000 description 1
- 229950008167 abamectin Drugs 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229960003790 alimemazine Drugs 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 229960004784 allergens Drugs 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
- 229960003942 amphotericin b Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 229940125687 antiparasitic agent Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- UESPXOLUEYJMTG-UHFFFAOYSA-N benzenesulfonic acid;n-[3-[6-methyl-3-(3-phenylpropyl)-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound OS(=O)(=O)C1=CC=CC=C1.C1C2C(C)(C=3C=C(NS(C)(=O)=O)C=CC=3)C2CN1CCCC1=CC=CC=C1 UESPXOLUEYJMTG-UHFFFAOYSA-N 0.000 description 1
- CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 229960002537 betamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 description 1
- VEMKTZHHVJILDY-UXHICEINSA-N bioresmethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-UXHICEINSA-N 0.000 description 1
- 239000012455 biphasic mixture Substances 0.000 description 1
- CHIWXYAWZYPFJS-UHFFFAOYSA-N bromomethoxybenzene Chemical compound BrCOC1=CC=CC=C1 CHIWXYAWZYPFJS-UHFFFAOYSA-N 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- WEDIIKBPDQQQJU-UHFFFAOYSA-N butane-1-sulfonyl chloride Chemical compound CCCCS(Cl)(=O)=O WEDIIKBPDQQQJU-UHFFFAOYSA-N 0.000 description 1
- WQQZDSNFMWOGLC-UHFFFAOYSA-N butanedioic acid;n-[3-[6-methyl-3-(3-phenylpropyl)-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound OC(=O)CCC(O)=O.C1C2C(C)(C=3C=C(NS(C)(=O)=O)C=CC=3)C2CN1CCCC1=CC=CC=C1 WQQZDSNFMWOGLC-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229960003184 carprofen Drugs 0.000 description 1
- IVUMCTKHWDRRMH-UHFFFAOYSA-N carprofen Chemical compound C1=CC(Cl)=C[C]2C3=CC=C(C(C(O)=O)C)C=C3N=C21 IVUMCTKHWDRRMH-UHFFFAOYSA-N 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 210000001638 cerebellum Anatomy 0.000 description 1
- 238000000451 chemical ionisation Methods 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- SOYKEARSMXGVTM-UHFFFAOYSA-N chlorphenamine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 SOYKEARSMXGVTM-UHFFFAOYSA-N 0.000 description 1
- 229960003291 chlorphenamine Drugs 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 238000009109 curative therapy Methods 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- FHHZOYXKOICLGH-UHFFFAOYSA-N dichloromethane;ethanol Chemical compound CCO.ClCCl FHHZOYXKOICLGH-UHFFFAOYSA-N 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical class OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- IEJIGPNLZYLLBP-UHFFFAOYSA-N dimethyl carbonate Chemical compound COC(=O)OC IEJIGPNLZYLLBP-UHFFFAOYSA-N 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 150000004887 dithianes Chemical class 0.000 description 1
- QLFZZSKTJWDQOS-YDBLARSUSA-N doramectin Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C3CCCCC3)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C QLFZZSKTJWDQOS-YDBLARSUSA-N 0.000 description 1
- 229960003997 doramectin Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229960005178 doxylamine Drugs 0.000 description 1
- HCFDWZZGGLSKEP-UHFFFAOYSA-N doxylamine Chemical compound C=1C=CC=NC=1C(C)(OCCN(C)C)C1=CC=CC=C1 HCFDWZZGGLSKEP-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 244000078703 ectoparasite Species 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 229960000740 enrofloxacin Drugs 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- AXCWTZKCUKAKQU-UHFFFAOYSA-N ethyl 2-(bromomethyl)-3-(3-nitrophenyl)cyclopropane-1-carboxylate Chemical compound CCOC(=O)C1C(CBr)C1C1=CC=CC([N+]([O-])=O)=C1 AXCWTZKCUKAKQU-UHFFFAOYSA-N 0.000 description 1
- FCZCIXQGZOUIDN-UHFFFAOYSA-N ethyl 2-diethoxyphosphinothioyloxyacetate Chemical compound CCOC(=O)COP(=S)(OCC)OCC FCZCIXQGZOUIDN-UHFFFAOYSA-N 0.000 description 1
- UHXJOLIZUSLHDY-UHFFFAOYSA-N ethyl 3-(3-hexyl-6-methyl-2-oxo-3-azabicyclo[3.1.0]hexan-6-yl)benzenecarboximidate Chemical compound O=C1N(CCCCCC)CC2C1C2(C)C1=CC=CC(C(=N)OCC)=C1 UHXJOLIZUSLHDY-UHFFFAOYSA-N 0.000 description 1
- RWNGRWRKPIQZCP-UHFFFAOYSA-N ethyl 3-(3-hexyl-6-methyl-2-oxo-3-azabicyclo[3.1.0]hexan-6-yl)benzenecarboximidate;hydrochloride Chemical compound Cl.O=C1N(CCCCCC)CC2C1C2(C)C1=CC=CC(C(=N)OCC)=C1 RWNGRWRKPIQZCP-UHFFFAOYSA-N 0.000 description 1
- MDLJDOQLSYBGOB-UHFFFAOYSA-N ethyl 3-(bromomethyl)-2-methyl-2-(3-nitrophenyl)cyclopropane-1-carboxylate Chemical compound CCOC(=O)C1C(CBr)C1(C)C1=CC=CC([N+]([O-])=O)=C1 MDLJDOQLSYBGOB-UHFFFAOYSA-N 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- PQVSTLUFSYVLTO-UHFFFAOYSA-N ethyl n-ethoxycarbonylcarbamate Chemical compound CCOC(=O)NC(=O)OCC PQVSTLUFSYVLTO-UHFFFAOYSA-N 0.000 description 1
- 229940013764 fipronil Drugs 0.000 description 1
- RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 description 1
- 229960004884 fluconazole Drugs 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 229940098330 gamma linoleic acid Drugs 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- DDUHZTYCFQRHIY-RBHXEPJQSA-N griseofulvin Chemical compound COC1=CC(=O)C[C@@H](C)[C@@]11C(=O)C(C(OC)=CC(OC)=C2Cl)=C2O1 DDUHZTYCFQRHIY-RBHXEPJQSA-N 0.000 description 1
- 229960002867 griseofulvin Drugs 0.000 description 1
- 125000004438 haloalkoxy group Chemical group 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- AKRQHOWXVSDJEF-UHFFFAOYSA-N heptane-1-sulfonic acid Chemical compound CCCCCCCS(O)(=O)=O AKRQHOWXVSDJEF-UHFFFAOYSA-N 0.000 description 1
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 1
- 229940046533 house dust mites Drugs 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 229940056881 imidacloprid Drugs 0.000 description 1
- YWTYJOPNNQFBPC-UHFFFAOYSA-N imidacloprid Chemical compound [O-][N+](=O)\N=C1/NCCN1CC1=CC=C(Cl)N=C1 YWTYJOPNNQFBPC-UHFFFAOYSA-N 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 230000000155 isotopic effect Effects 0.000 description 1
- 229960004130 itraconazole Drugs 0.000 description 1
- 229960002418 ivermectin Drugs 0.000 description 1
- 229960004125 ketoconazole Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- JNODQFNWMXFMEV-UHFFFAOYSA-N latrepirdine Chemical compound C1N(C)CCC2=C1C1=CC(C)=CC=C1N2CCC1=CC=C(C)N=C1 JNODQFNWMXFMEV-UHFFFAOYSA-N 0.000 description 1
- 231100001231 less toxic Toxicity 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 1
- 229940040692 lithium hydroxide monohydrate Drugs 0.000 description 1
- GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium hydroxide monohydrate Substances [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 description 1
- 229960000521 lufenuron Drugs 0.000 description 1
- PWPJGUXAGUPAHP-UHFFFAOYSA-N lufenuron Chemical compound C1=C(Cl)C(OC(F)(F)C(C(F)(F)F)F)=CC(Cl)=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F PWPJGUXAGUPAHP-UHFFFAOYSA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 229960002531 marbofloxacin Drugs 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- OVPUMPRLULLWGW-UHFFFAOYSA-N methanesulfonamide;4-methylbenzenesulfonic acid Chemical compound CS(N)(=O)=O.CC1=CC=C(S(O)(=O)=O)C=C1 OVPUMPRLULLWGW-UHFFFAOYSA-N 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 description 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
- FXWHFKOXMBTCMP-WMEDONTMSA-N milbemycin Natural products COC1C2OCC3=C/C=C/C(C)CC(=CCC4CC(CC5(O4)OC(C)C(C)C(OC(=O)C(C)CC(C)C)C5O)OC(=O)C(C=C1C)C23O)C FXWHFKOXMBTCMP-WMEDONTMSA-N 0.000 description 1
- ZLBGSRMUSVULIE-GSMJGMFJSA-N milbemycin A3 Chemical class O1[C@H](C)[C@@H](C)CC[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 ZLBGSRMUSVULIE-GSMJGMFJSA-N 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- JFCHSQDLLFJHOA-UHFFFAOYSA-N n,n-dimethylsulfamoyl chloride Chemical compound CN(C)S(Cl)(=O)=O JFCHSQDLLFJHOA-UHFFFAOYSA-N 0.000 description 1
- KAZYDFSSPZJVAX-UHFFFAOYSA-N n-[2,4-dichloro-3-(3-hexyl-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl)phenyl]methanesulfonamide Chemical compound C1N(CCCCCC)CC2C1C2(C)C1=C(Cl)C=CC(NS(C)(=O)=O)=C1Cl KAZYDFSSPZJVAX-UHFFFAOYSA-N 0.000 description 1
- SLJXAMHPZDNZDM-UHFFFAOYSA-N n-[2,4-dichloro-5-(3-hexyl-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl)phenyl]methanesulfonamide Chemical compound C1N(CCCCCC)CC2C1C2(C)C1=CC(NS(C)(=O)=O)=C(Cl)C=C1Cl SLJXAMHPZDNZDM-UHFFFAOYSA-N 0.000 description 1
- VOMNPLYRSGRRFN-UHFFFAOYSA-N n-[2-(3-hexyl-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl)phenyl]methanesulfonamide Chemical compound C1N(CCCCCC)CC2C1C2(C)C1=CC=CC=C1NS(C)(=O)=O VOMNPLYRSGRRFN-UHFFFAOYSA-N 0.000 description 1
- FUYOSWGNQNMYAU-UHFFFAOYSA-N n-[3-(3-benzyl-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl)phenyl]methanesulfonamide Chemical compound C1C2C(C)(C=3C=C(NS(C)(=O)=O)C=CC=3)C2CN1CC1=CC=CC=C1 FUYOSWGNQNMYAU-UHFFFAOYSA-N 0.000 description 1
- YCJQOMOFUASUJU-UHFFFAOYSA-N n-[3-(3-hexyl-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl)phenyl]-1-methylimidazole-4-sulfonamide Chemical compound C1N(CCCCCC)CC2C1C2(C)C(C=1)=CC=CC=1NS(=O)(=O)C1=CN(C)C=N1 YCJQOMOFUASUJU-UHFFFAOYSA-N 0.000 description 1
- COZMLEGAZKKASC-UHFFFAOYSA-N n-[3-(3-hexyl-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl)phenyl]-2,1,3-benzoxadiazole-4-sulfonamide Chemical compound C1=CC2=NON=C2C(S(=O)(=O)NC=2C=CC=C(C=2)C2(C)C3C2CN(C3)CCCCCC)=C1 COZMLEGAZKKASC-UHFFFAOYSA-N 0.000 description 1
- QDQBQCJGFKKXGS-UHFFFAOYSA-N n-[3-(3-hexyl-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl)phenyl]-2-hydroxyethanesulfonamide Chemical compound C1N(CCCCCC)CC2C1C2(C)C1=CC=CC(NS(=O)(=O)CCO)=C1 QDQBQCJGFKKXGS-UHFFFAOYSA-N 0.000 description 1
- PYEHXIXWXPNFCN-UHFFFAOYSA-N n-[3-(3-hexyl-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl)phenyl]-2-methoxyethanesulfonamide Chemical compound C1N(CCCCCC)CC2C1C2(C)C1=CC=CC(NS(=O)(=O)CCOC)=C1 PYEHXIXWXPNFCN-UHFFFAOYSA-N 0.000 description 1
- SAVHAEUUKIIEKG-UHFFFAOYSA-N n-[3-(3-hexyl-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl)phenyl]butane-1-sulfonamide Chemical compound C1N(CCCCCC)CC2C1C2(C)C1=CC=CC(NS(=O)(=O)CCCC)=C1 SAVHAEUUKIIEKG-UHFFFAOYSA-N 0.000 description 1
- PWDNXINZGQFROJ-UHFFFAOYSA-N n-[3-(3-hexyl-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl)phenyl]ethanesulfonamide Chemical compound C1N(CCCCCC)CC2C1C2(C)C1=CC=CC(NS(=O)(=O)CC)=C1 PWDNXINZGQFROJ-UHFFFAOYSA-N 0.000 description 1
- BGSMMAKOLDHTCH-UHFFFAOYSA-N n-[3-(3-hexyl-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl)phenyl]isoquinoline-5-sulfonamide Chemical compound N1=CC=C2C(S(=O)(=O)NC=3C=CC=C(C=3)C3(C)C4C3CN(C4)CCCCCC)=CC=CC2=C1 BGSMMAKOLDHTCH-UHFFFAOYSA-N 0.000 description 1
- OWZMGDCDTNNHGX-UHFFFAOYSA-N n-[3-(3-hexyl-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl)phenyl]propane-1-sulfonamide Chemical compound C1N(CCCCCC)CC2C1C2(C)C1=CC=CC(NS(=O)(=O)CCC)=C1 OWZMGDCDTNNHGX-UHFFFAOYSA-N 0.000 description 1
- DWOWQHRBEPAFKK-UHFFFAOYSA-N n-[3-(3-hexyl-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl)phenyl]propane-2-sulfonamide Chemical compound C1N(CCCCCC)CC2C1C2(C)C1=CC=CC(NS(=O)(=O)C(C)C)=C1 DWOWQHRBEPAFKK-UHFFFAOYSA-N 0.000 description 1
- WYKMFEQACYTFHA-UHFFFAOYSA-N n-[3-(3-hexyl-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl)phenyl]pyridine-3-sulfonamide Chemical compound C1N(CCCCCC)CC2C1C2(C)C(C=1)=CC=CC=1NS(=O)(=O)C1=CC=CN=C1 WYKMFEQACYTFHA-UHFFFAOYSA-N 0.000 description 1
- CKBZRYWPXUWECL-UHFFFAOYSA-N n-[3-(3-hexyl-6-propan-2-yl-3-azabicyclo[3.1.0]hexan-6-yl)phenyl]methanesulfonamide Chemical compound C1N(CCCCCC)CC2C1C2(C(C)C)C1=CC=CC(NS(C)(=O)=O)=C1 CKBZRYWPXUWECL-UHFFFAOYSA-N 0.000 description 1
- JUCCUNKUZWGLKZ-UHFFFAOYSA-N n-[3-(3-hexyl-6-propyl-3-azabicyclo[3.1.0]hexan-6-yl)phenyl]methanesulfonamide Chemical compound C1N(CCCCCC)CC2C1C2(CCC)C1=CC=CC(NS(C)(=O)=O)=C1 JUCCUNKUZWGLKZ-UHFFFAOYSA-N 0.000 description 1
- ONOHVJONOXEFSN-UHFFFAOYSA-N n-[3-(6-ethyl-3-hexyl-3-azabicyclo[3.1.0]hexan-6-yl)phenyl]ethanesulfonamide Chemical compound C1N(CCCCCC)CC2C1C2(CC)C1=CC=CC(NS(=O)(=O)CC)=C1 ONOHVJONOXEFSN-UHFFFAOYSA-N 0.000 description 1
- UQSVQFROXHNXQA-UHFFFAOYSA-N n-[3-(6-ethyl-3-hexyl-3-azabicyclo[3.1.0]hexan-6-yl)phenyl]methanesulfonamide Chemical compound C1N(CCCCCC)CC2C1C2(CC)C1=CC=CC(NS(C)(=O)=O)=C1 UQSVQFROXHNXQA-UHFFFAOYSA-N 0.000 description 1
- QSVPVVPZWNUMCP-UHFFFAOYSA-N n-[3-(6-methyl-3-azabicyclo[3.1.0]hexan-6-yl)phenyl]methanesulfonamide;hydrochloride Chemical compound Cl.C12CNCC2C1(C)C1=CC=CC(NS(C)(=O)=O)=C1 QSVPVVPZWNUMCP-UHFFFAOYSA-N 0.000 description 1
- FWRDVYVXDYNTJJ-UHFFFAOYSA-N n-[3-(6-methyl-3-prop-2-enyl-3-azabicyclo[3.1.0]hexan-6-yl)phenyl]methanesulfonamide Chemical compound C12CN(CC=C)CC2C1(C)C1=CC=CC(NS(C)(=O)=O)=C1 FWRDVYVXDYNTJJ-UHFFFAOYSA-N 0.000 description 1
- ONQPODLLXFYQRO-UHFFFAOYSA-N n-[3-[3-(1-benzofuran-2-carbonyl)-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C12CN(C(=O)C=3OC4=CC=CC=C4C=3)CC2C1(C)C1=CC=CC(NS(C)(=O)=O)=C1 ONQPODLLXFYQRO-UHFFFAOYSA-N 0.000 description 1
- HOAFXSCRJTUBTO-UHFFFAOYSA-N n-[3-[3-(1-benzothiophene-2-carbonyl)-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C12CN(C(=O)C=3SC4=CC=CC=C4C=3)CC2C1(C)C1=CC=CC(NS(C)(=O)=O)=C1 HOAFXSCRJTUBTO-UHFFFAOYSA-N 0.000 description 1
- ZBGCZODFLAJHRY-UHFFFAOYSA-N n-[3-[3-(2,3-dihydro-1h-indene-2-carbonyl)-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C12CN(C(=O)C3CC4=CC=CC=C4C3)CC2C1(C)C1=CC=CC(NS(C)(=O)=O)=C1 ZBGCZODFLAJHRY-UHFFFAOYSA-N 0.000 description 1
- SPNKLRRAVKCBFI-UHFFFAOYSA-N n-[3-[3-(2-butoxyethyl)-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C1N(CCOCCCC)CC2C1C2(C)C1=CC=CC(NS(C)(=O)=O)=C1 SPNKLRRAVKCBFI-UHFFFAOYSA-N 0.000 description 1
- CQJHYVMKTHVYPY-UHFFFAOYSA-N n-[3-[3-(3-cyclohexylpropyl)-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]ethanesulfonamide Chemical compound CCS(=O)(=O)NC1=CC=CC(C2(C)C3CN(CCCC4CCCCC4)CC32)=C1 CQJHYVMKTHVYPY-UHFFFAOYSA-N 0.000 description 1
- RNIZMXXTCCITTO-UHFFFAOYSA-N n-[3-[3-(3-phenylpropyl)-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound CS(=O)(=O)NC1=CC=CC(C2C3CN(CCCC=4C=CC=CC=4)CC32)=C1 RNIZMXXTCCITTO-UHFFFAOYSA-N 0.000 description 1
- RRNYWUXRAVOODO-UHFFFAOYSA-N n-[3-[3-[2-(1h-indol-3-yl)ethyl]-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C12CN(CCC=3C4=CC=CC=C4NC=3)CC2C1(C)C1=CC=CC(NS(C)(=O)=O)=C1 RRNYWUXRAVOODO-UHFFFAOYSA-N 0.000 description 1
- YRKJKTDSJAQSRB-UHFFFAOYSA-N n-[3-[3-[2-(2-chlorophenyl)ethyl]-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C1C2C(C)(C=3C=C(NS(C)(=O)=O)C=CC=3)C2CN1CCC1=CC=CC=C1Cl YRKJKTDSJAQSRB-UHFFFAOYSA-N 0.000 description 1
- CYTRKUCPYOFEMR-UHFFFAOYSA-N n-[3-[3-[2-(5-chlorothiophen-3-yl)acetyl]-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C1C2C(C)(C=3C=C(NS(C)(=O)=O)C=CC=3)C2CN1C(=O)CC1=CSC(Cl)=C1 CYTRKUCPYOFEMR-UHFFFAOYSA-N 0.000 description 1
- YBTVYSZKBXSGJS-UHFFFAOYSA-N n-[3-[3-[3-(1,3-benzodioxol-5-yl)propyl]-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C12CN(CCCC=3C=C4OCOC4=CC=3)CC2C1(C)C1=CC=CC(NS(C)(=O)=O)=C1 YBTVYSZKBXSGJS-UHFFFAOYSA-N 0.000 description 1
- FVAWPTXYVJEFSL-UHFFFAOYSA-N n-[3-[3-[3-(1h-indol-3-yl)propanoyl]-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C12CN(C(=O)CCC=3C4=CC=CC=C4NC=3)CC2C1(C)C1=CC=CC(NS(C)(=O)=O)=C1 FVAWPTXYVJEFSL-UHFFFAOYSA-N 0.000 description 1
- ZXLOATSYKXAGNV-UHFFFAOYSA-N n-[3-[3-[3-(1h-indol-3-yl)propyl]-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C12CN(CCCC=3C4=CC=CC=C4NC=3)CC2C1(C)C1=CC=CC(NS(C)(=O)=O)=C1 ZXLOATSYKXAGNV-UHFFFAOYSA-N 0.000 description 1
- XUSBDZCHVFZVIF-UHFFFAOYSA-N n-[3-[3-[3-(2-chlorophenyl)propanoyl]-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C1C2C(C)(C=3C=C(NS(C)(=O)=O)C=CC=3)C2CN1C(=O)CCC1=CC=CC=C1Cl XUSBDZCHVFZVIF-UHFFFAOYSA-N 0.000 description 1
- JODUBQZNBBRJOP-UHFFFAOYSA-N n-[3-[3-[3-(2-methoxyphenyl)propanoyl]-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound COC1=CC=CC=C1CCC(=O)N1CC(C2(C)C=3C=C(NS(C)(=O)=O)C=CC=3)C2C1 JODUBQZNBBRJOP-UHFFFAOYSA-N 0.000 description 1
- QRELFFWWDXXDBH-UHFFFAOYSA-N n-[3-[3-[3-(3,4-dichlorophenyl)propanoyl]-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C1C2C(C)(C=3C=C(NS(C)(=O)=O)C=CC=3)C2CN1C(=O)CCC1=CC=C(Cl)C(Cl)=C1 QRELFFWWDXXDBH-UHFFFAOYSA-N 0.000 description 1
- KZGYVBSDOMTRBP-UHFFFAOYSA-N n-[3-[3-[3-(4-fluorophenyl)propanoyl]-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C1C2C(C)(C=3C=C(NS(C)(=O)=O)C=CC=3)C2CN1C(=O)CCC1=CC=C(F)C=C1 KZGYVBSDOMTRBP-UHFFFAOYSA-N 0.000 description 1
- TYLDXEQZODIDQV-UHFFFAOYSA-N n-[3-[3-[3-(5-fluoro-3-methyl-1h-indol-2-yl)propanoyl]-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound N1C2=CC=C(F)C=C2C(C)=C1CCC(=O)N(C1)CC2C1C2(C)C1=CC=CC(NS(C)(=O)=O)=C1 TYLDXEQZODIDQV-UHFFFAOYSA-N 0.000 description 1
- SNWKOKKRSGVCJL-UHFFFAOYSA-N n-[3-[3-[[4-(cyanomethyl)phenyl]methyl]-6-methyl-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C1C2C(C)(C=3C=C(NS(C)(=O)=O)C=CC=3)C2CN1CC1=CC=C(CC#N)C=C1 SNWKOKKRSGVCJL-UHFFFAOYSA-N 0.000 description 1
- WLUPBBKVFAVJST-UHFFFAOYSA-N n-[3-[6-methyl-3-(3-methyl-3-phenylbutanoyl)-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C=1C=CC=CC=1C(C)(C)CC(=O)N(C1)CC2C1C2(C)C1=CC=CC(NS(C)(=O)=O)=C1 WLUPBBKVFAVJST-UHFFFAOYSA-N 0.000 description 1
- KPVZTTRURLMSCX-UHFFFAOYSA-N n-[3-[6-methyl-3-(3-phenoxypropyl)-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C1C2C(C)(C=3C=C(NS(C)(=O)=O)C=CC=3)C2CN1CCCOC1=CC=CC=C1 KPVZTTRURLMSCX-UHFFFAOYSA-N 0.000 description 1
- AWDCIIQULDNCNQ-UHFFFAOYSA-N n-[3-[6-methyl-3-(3-pyridin-2-ylpropanoyl)-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C1C2C(C)(C=3C=C(NS(C)(=O)=O)C=CC=3)C2CN1C(=O)CCC1=CC=CC=N1 AWDCIIQULDNCNQ-UHFFFAOYSA-N 0.000 description 1
- UJDHSMOTRDQXAL-UHFFFAOYSA-N n-[3-[6-methyl-3-(3-pyridin-4-ylpropanoyl)-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C1C2C(C)(C=3C=C(NS(C)(=O)=O)C=CC=3)C2CN1C(=O)CCC1=CC=NC=C1 UJDHSMOTRDQXAL-UHFFFAOYSA-N 0.000 description 1
- BIWNMPGGHDVQDA-UHFFFAOYSA-N n-[3-[6-methyl-3-(3-thiophen-2-ylpropanoyl)-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C1C2C(C)(C=3C=C(NS(C)(=O)=O)C=CC=3)C2CN1C(=O)CCC1=CC=CS1 BIWNMPGGHDVQDA-UHFFFAOYSA-N 0.000 description 1
- HFBSCJZHCLHTIH-UHFFFAOYSA-N n-[3-[6-methyl-3-(3-thiophen-2-ylpropyl)-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C1C2C(C)(C=3C=C(NS(C)(=O)=O)C=CC=3)C2CN1CCCC1=CC=CS1 HFBSCJZHCLHTIH-UHFFFAOYSA-N 0.000 description 1
- CDZAENNQANZRQH-UHFFFAOYSA-N n-[3-[6-methyl-3-(3-thiophen-3-ylpropanoyl)-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C1C2C(C)(C=3C=C(NS(C)(=O)=O)C=CC=3)C2CN1C(=O)CCC=1C=CSC=1 CDZAENNQANZRQH-UHFFFAOYSA-N 0.000 description 1
- AUTQUGHSQONPNZ-UHFFFAOYSA-N n-[3-[6-methyl-3-(3-thiophen-3-ylpropyl)-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C1C2C(C)(C=3C=C(NS(C)(=O)=O)C=CC=3)C2CN1CCCC=1C=CSC=1 AUTQUGHSQONPNZ-UHFFFAOYSA-N 0.000 description 1
- WGPGHCISZMBEJR-UHFFFAOYSA-N n-[3-[6-methyl-3-(4-phenylbutanoyl)-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C1C2C(C)(C=3C=C(NS(C)(=O)=O)C=CC=3)C2CN1C(=O)CCCC1=CC=CC=C1 WGPGHCISZMBEJR-UHFFFAOYSA-N 0.000 description 1
- HCFZQSLNHMREOX-BQYQJAHWSA-N n-[3-[6-methyl-3-[(e)-3-(3-methylthiophen-2-yl)prop-2-enoyl]-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C1=CSC(\C=C\C(=O)N2CC3C(C3(C)C=3C=C(NS(C)(=O)=O)C=CC=3)C2)=C1C HCFZQSLNHMREOX-BQYQJAHWSA-N 0.000 description 1
- NLGAZMMQPVQFTQ-ZHACJKMWSA-N n-[3-[6-methyl-3-[(e)-3-(6-methylpyridin-2-yl)prop-2-enoyl]-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound CC1=CC=CC(\C=C\C(=O)N2CC3C(C3(C)C=3C=C(NS(C)(=O)=O)C=CC=3)C2)=N1 NLGAZMMQPVQFTQ-ZHACJKMWSA-N 0.000 description 1
- COQYRMPWIXWEKP-ZHACJKMWSA-N n-[3-[6-methyl-3-[(e)-3-[2-(trifluoromethyl)phenyl]prop-2-enoyl]-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C1C2C(C)(C=3C=C(NS(C)(=O)=O)C=CC=3)C2CN1C(=O)\C=C\C1=CC=CC=C1C(F)(F)F COQYRMPWIXWEKP-ZHACJKMWSA-N 0.000 description 1
- VMHZABXTTXMGTK-MDZDMXLPSA-N n-[3-[6-methyl-3-[(e)-3-pyridin-2-ylprop-2-enoyl]-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C1C2C(C)(C=3C=C(NS(C)(=O)=O)C=CC=3)C2CN1C(=O)\C=C\C1=CC=CC=N1 VMHZABXTTXMGTK-MDZDMXLPSA-N 0.000 description 1
- BAEDCYDXRZVDHX-UXBLZVDNSA-N n-[3-[6-methyl-3-[(e)-3-pyridin-2-ylprop-2-enyl]-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C1C2C(C)(C=3C=C(NS(C)(=O)=O)C=CC=3)C2CN1C\C=C\C1=CC=CC=N1 BAEDCYDXRZVDHX-UXBLZVDNSA-N 0.000 description 1
- FWSSKGYNGCUSEA-OUKQBFOZSA-N n-[3-[6-methyl-3-[(e)-3-quinolin-2-ylprop-2-enoyl]-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C12CN(C(=O)\C=C\C=3N=C4C=CC=CC4=CC=3)CC2C1(C)C1=CC=CC(NS(C)(=O)=O)=C1 FWSSKGYNGCUSEA-OUKQBFOZSA-N 0.000 description 1
- XXYZILJYFIKFJT-CMDGGOBGSA-N n-[3-[6-methyl-3-[(e)-3-thiophen-2-ylprop-2-enoyl]-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C1C2C(C)(C=3C=C(NS(C)(=O)=O)C=CC=3)C2CN1C(=O)\C=C\C1=CC=CS1 XXYZILJYFIKFJT-CMDGGOBGSA-N 0.000 description 1
- ZPCXTYGXXATZCJ-VOTSOKGWSA-N n-[3-[6-methyl-3-[(e)-3-thiophen-3-ylprop-2-enoyl]-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C1C2C(C)(C=3C=C(NS(C)(=O)=O)C=CC=3)C2CN1C(=O)\C=C\C=1C=CSC=1 ZPCXTYGXXATZCJ-VOTSOKGWSA-N 0.000 description 1
- NMGCITCQBDOEBU-UHFFFAOYSA-N n-[3-[6-methyl-3-[2-(1-methylindol-3-yl)acetyl]-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C12=CC=CC=C2N(C)C=C1CC(=O)N(C1)CC2C1C2(C)C1=CC=CC(NS(C)(=O)=O)=C1 NMGCITCQBDOEBU-UHFFFAOYSA-N 0.000 description 1
- IKVDAZOMKCRSCZ-UHFFFAOYSA-N n-[3-[6-methyl-3-[2-(1-methylindol-3-yl)ethyl]-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C12=CC=CC=C2N(C)C=C1CCN(C1)CC2C1C2(C)C1=CC=CC(NS(C)(=O)=O)=C1 IKVDAZOMKCRSCZ-UHFFFAOYSA-N 0.000 description 1
- WSKJCKMKDJSFJM-UHFFFAOYSA-N n-[3-[6-methyl-3-[2-[4-(trifluoromethyl)phenyl]acetyl]-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C1C2C(C)(C=3C=C(NS(C)(=O)=O)C=CC=3)C2CN1C(=O)CC1=CC=C(C(F)(F)F)C=C1 WSKJCKMKDJSFJM-UHFFFAOYSA-N 0.000 description 1
- MIAAJXKWYVCABZ-UHFFFAOYSA-N n-[3-[6-methyl-3-[2-[4-(trifluoromethyl)phenyl]ethyl]-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C1C2C(C)(C=3C=C(NS(C)(=O)=O)C=CC=3)C2CN1CCC1=CC=C(C(F)(F)F)C=C1 MIAAJXKWYVCABZ-UHFFFAOYSA-N 0.000 description 1
- QDXRGAXZTXKZMC-UHFFFAOYSA-N n-[3-[6-methyl-3-[3-(3-methylthiophen-2-yl)propanoyl]-3-azabicyclo[3.1.0]hexan-6-yl]phenyl]methanesulfonamide Chemical compound C1=CSC(CCC(=O)N2CC3C(C3(C)C=3C=C(NS(C)(=O)=O)C=CC=3)C2)=C1C QDXRGAXZTXKZMC-UHFFFAOYSA-N 0.000 description 1
- HYFBSNNRTFANFZ-UHFFFAOYSA-N n-[[6-(3-aminophenyl)-3-hexyl-3-azabicyclo[3.1.0]hexan-6-yl]methyl]acetamide Chemical compound C1N(CCCCCC)CC2C1C2(CNC(C)=O)C1=CC=CC(N)=C1 HYFBSNNRTFANFZ-UHFFFAOYSA-N 0.000 description 1
- FTNFEHXDETWERN-UHFFFAOYSA-N n-[bis(aziridin-1-yl)phosphoryl]-2,6-dimethyl-5-[(4-propan-2-yloxyphenyl)methyl]pyrimidin-4-amine Chemical compound C1=CC(OC(C)C)=CC=C1CC1=C(C)N=C(C)N=C1NP(=O)(N1CC1)N1CC1 FTNFEHXDETWERN-UHFFFAOYSA-N 0.000 description 1
- XHXVAJHZTIXQQD-UHFFFAOYSA-N n-[bis(aziridin-1-yl)phosphoryl]-5-[(4-butoxyphenyl)methyl]-2,6-dimethylpyrimidin-4-amine Chemical compound C1=CC(OCCCC)=CC=C1CC1=C(C)N=C(C)N=C1NP(=O)(N1CC1)N1CC1 XHXVAJHZTIXQQD-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 239000003887 narcotic antagonist Substances 0.000 description 1
- 239000003176 neuroleptic agent Substances 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- XITQUSLLOSKDTB-UHFFFAOYSA-N nitrofen Chemical compound C1=CC([N+](=O)[O-])=CC=C1OC1=CC=C(Cl)C=C1Cl XITQUSLLOSKDTB-UHFFFAOYSA-N 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- 238000002414 normal-phase solid-phase extraction Methods 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- OAHKWDDSKCRNFE-UHFFFAOYSA-N phenylmethanesulfonyl chloride Chemical compound ClS(=O)(=O)CC1=CC=CC=C1 OAHKWDDSKCRNFE-UHFFFAOYSA-N 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000004540 pour-on Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 229960005205 prednisolone Drugs 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 150000003138 primary alcohols Chemical class 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- DRINJBFRTLBHNF-UHFFFAOYSA-N propane-2-sulfonyl chloride Chemical compound CC(C)S(Cl)(=O)=O DRINJBFRTLBHNF-UHFFFAOYSA-N 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- CDRNYKLYADJTMN-UHFFFAOYSA-N pyridine-3-sulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CN=C1 CDRNYKLYADJTMN-UHFFFAOYSA-N 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- SYBXSZMNKDOUCA-UHFFFAOYSA-J rhodium(2+);tetraacetate Chemical compound [Rh+2].[Rh+2].CC([O-])=O.CC([O-])=O.CC([O-])=O.CC([O-])=O SYBXSZMNKDOUCA-UHFFFAOYSA-J 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000004544 spot-on Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 description 1
- VBMHLJHEUUUOEG-UHFFFAOYSA-N sulfuric acid sulfur trioxide Chemical compound S(O)(O)(=O)=O.S(=O)(=O)=O.S(O)(O)(=O)=O VBMHLJHEUUUOEG-UHFFFAOYSA-N 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000010414 supernatant solution Substances 0.000 description 1
- FKHIFSZMMVMEQY-UHFFFAOYSA-N talc Chemical compound [Mg+2].[O-][Si]([O-])=O FKHIFSZMMVMEQY-UHFFFAOYSA-N 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 125000001981 tert-butyldimethylsilyl group Chemical group [H]C([H])([H])[Si]([H])(C([H])([H])[H])[*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000000037 tert-butyldiphenylsilyl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1[Si]([H])([*]C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- UWHCKJMYHZGTIT-UHFFFAOYSA-N tetraethylene glycol Chemical compound OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- GRGCWBWNLSTIEN-UHFFFAOYSA-N trifluoromethanesulfonyl chloride Chemical compound FC(F)(F)S(Cl)(=O)=O GRGCWBWNLSTIEN-UHFFFAOYSA-N 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 108700026215 vpr Genes Proteins 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Addiction (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Reproductive Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9828485.4A GB9828485D0 (en) | 1998-12-23 | 1998-12-23 | Compounds useful in therapy |
GBGB9912425.7A GB9912425D0 (en) | 1999-05-27 | 1999-05-27 | Compounds useful in therapy |
PCT/IB1999/001852 WO2000039089A1 (fr) | 1998-12-23 | 1999-11-19 | Derives 3-azabicyclo[3.1.0] hexane utilises comme ligands de recepteurs d'opiaces |
US09/467,871 US6313312B1 (en) | 1998-12-23 | 1999-12-20 | 3-Azabicyclo[3.1.0]hexane derivatives useful in therapy |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20013148D0 NO20013148D0 (no) | 2001-06-22 |
NO20013148L NO20013148L (no) | 2001-08-23 |
NO321658B1 true NO321658B1 (no) | 2006-06-19 |
Family
ID=27269601
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20013148A NO321658B1 (no) | 1998-12-23 | 2001-06-22 | 3-Azabicyklo[3.1.0]heksanderivater som opiatreceptorligander |
Country Status (33)
Country | Link |
---|---|
US (3) | US6313312B1 (fr) |
EP (1) | EP1140828B1 (fr) |
JP (1) | JP3553886B2 (fr) |
CN (1) | CN1192021C (fr) |
AP (1) | AP1852A (fr) |
AT (1) | ATE335725T1 (fr) |
AU (1) | AU761574B2 (fr) |
BG (1) | BG65402B1 (fr) |
BR (1) | BR9916584A (fr) |
CA (1) | CA2356300C (fr) |
CY (1) | CY1106445T1 (fr) |
CZ (1) | CZ20012299A3 (fr) |
DE (1) | DE69932738T2 (fr) |
DK (1) | DK1140828T3 (fr) |
DZ (1) | DZ2962A1 (fr) |
EA (1) | EA004672B1 (fr) |
ES (1) | ES2274646T3 (fr) |
HK (1) | HK1041698B (fr) |
HR (1) | HRP20010477B1 (fr) |
HU (1) | HUP0104816A3 (fr) |
ID (1) | ID28981A (fr) |
IL (1) | IL142697A0 (fr) |
IS (1) | IS2467B (fr) |
MA (1) | MA25035A1 (fr) |
NO (1) | NO321658B1 (fr) |
NZ (1) | NZ511234A (fr) |
OA (1) | OA11727A (fr) |
PL (1) | PL348453A1 (fr) |
SI (1) | SI1140828T1 (fr) |
SK (1) | SK8772001A3 (fr) |
TW (1) | TWI244481B (fr) |
UY (1) | UY25873A1 (fr) |
WO (1) | WO2000039089A1 (fr) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI244481B (en) * | 1998-12-23 | 2005-12-01 | Pfizer | 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
GB9912416D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912411D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912413D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912415D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912410D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912417D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
US20030207876A1 (en) * | 2000-06-23 | 2003-11-06 | Banks Bernard Joseph | 3-Azabicyclo[3.1.0]hexane derivatives useful in therapy |
GB0015562D0 (en) * | 2000-06-23 | 2000-08-16 | Pfizer Ltd | Heterocycles |
JP4155522B2 (ja) * | 2001-10-22 | 2008-09-24 | ファイザー・プロダクツ・インク | オピオイド受容体アンタゴニストとしての3−アザビシクロ(3.1.0)ヘキサン誘導体 |
MXPA05000434A (es) | 2002-07-08 | 2005-04-19 | Ranbaxy Lab Ltd | Derivados de hexano [3.1.0] azabiciclo 3,6-disustituido utiles como antagonistas de receptor muscarinico. |
US7265147B2 (en) * | 2002-07-31 | 2007-09-04 | Ranbaxy Laboratories Limited | 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
DE60231341D1 (de) * | 2002-08-23 | 2009-04-09 | Ranbaxy Lab Ltd | Fluor- und sulfonylaminohaltige, 3,6-disubstituierptorantagonisten |
US7488748B2 (en) * | 2003-01-28 | 2009-02-10 | Ranbaxy Laboratories Limited | 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
BRPI0409217A (pt) * | 2003-04-09 | 2006-03-28 | Pharmacia & Upjohn Co Llc | derivados e análogos antimicrobianos da [3.1.0]bicicloexilfeniloxazolidinona |
WO2004089898A1 (fr) * | 2003-04-09 | 2004-10-21 | Ranbaxy Laboratories Limited | Derives d'azabicyclo hexane substitues en tant qu'antagonistes de recepteurs muscariniques |
CN100436414C (zh) * | 2003-04-11 | 2008-11-26 | 兰贝克赛实验室有限公司 | 作为毒蕈碱受体拮抗剂的氮杂双环衍生物 |
WO2004089908A2 (fr) * | 2003-04-14 | 2004-10-21 | Pfizer Products Inc. | Derives de 3-azabicyclo[3.2.1]octane |
MXPA06004278A (es) * | 2003-10-16 | 2006-06-28 | Pfizer Prod Inc | Preparacion de derivados de 3-azabiciclo [3.1.0]hexano. |
MX2007002136A (es) * | 2004-09-01 | 2007-04-02 | Pfizer Prod Inc | Antagonistas amino azabiciclicos del receptor 3 de la histamina. |
WO2006113458A1 (fr) * | 2005-04-15 | 2006-10-26 | Bristol-Myers Squibb Company | Inhibiteurs heterocycliques des proteines arginine methyle transferases |
US20080319043A1 (en) * | 2005-05-03 | 2008-12-25 | Mohammad Salman | 3,6-Disubstituted Azabicyclo (3.1.0) Hexane Derivatives as Muscarinic Receptor Antagonists |
US20070015138A1 (en) * | 2005-07-08 | 2007-01-18 | Braincells, Inc. | Methods for identifying agents and conditions that modulate neurogenesis |
GB0517187D0 (en) * | 2005-08-22 | 2005-09-28 | Glaxo Group Ltd | Compounds |
GB0517193D0 (en) | 2005-08-22 | 2005-09-28 | Glaxo Group Ltd | Novel use |
US7799815B2 (en) * | 2005-08-22 | 2010-09-21 | Glaxo Group Limited | Triazole derivatives as modulators of dopamine D3 receptors |
GB0517191D0 (en) * | 2005-08-22 | 2005-09-28 | Glaxo Group Ltd | Compounds |
MY145633A (en) | 2006-03-01 | 2012-03-15 | Theravance Inc | 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
TWI409067B (zh) * | 2007-02-28 | 2013-09-21 | Theravance Inc | 8-氮雜雙環〔3.2.1〕辛烷化合物之結晶型 |
GB0716632D0 (en) * | 2007-08-24 | 2007-10-03 | Glaxo Group Ltd | Compounds |
TWI423801B (zh) * | 2007-08-27 | 2014-01-21 | Theravance Inc | 作為μ類鴉片受體拮抗劑之8-氮雜雙環〔3.2.1〕辛基-2-羥基苯甲醯胺化合物 |
US7691878B2 (en) * | 2007-08-27 | 2010-04-06 | Theravance, Inc. | Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists |
WO2009029257A1 (fr) * | 2007-08-27 | 2009-03-05 | Theravance, Inc. | Composes d'alkyl-8-azabicyclo[3.2.1.]octane disubstitutes utilises en tant qu'antagonistes du recepteur opioide mu |
ES2390195T3 (es) * | 2007-08-27 | 2012-11-07 | Theravance, Inc. | Compuestos de amidoalquil-8-azabiciclo(3,2,1)octano, como antagonistas del receptor opioide mu |
DE102010040233A1 (de) | 2010-09-03 | 2012-03-08 | Bayer Schering Pharma Aktiengesellschaft | Bicyclische Aza-Heterocyclen und ihre Verwendung |
JP2013542929A (ja) | 2010-09-28 | 2013-11-28 | パナセア バイオテック リミテッド | 新規ビシクロ環化合物 |
JP6041886B2 (ja) | 2011-11-07 | 2016-12-14 | スノヴィオン ファーマシューティカルズ インコーポレイテッドSunovion Pharmaceuticals Inc. | オピオイド受容体の調節物質およびそれを含む薬学的組成物 |
AU2014354085B2 (en) | 2013-11-20 | 2018-04-26 | Ube Corporation | Novel 3-azabicyclo[3.1.0]hexane derivative and use thereof for medical purposes |
WO2015117146A1 (fr) | 2014-02-03 | 2015-08-06 | Quadriga Biosciences, Inc. | Acides gamma-aminés bêta-substitués et analogues en tant qu'agents chimiothérapeutiques |
EP3102195B1 (fr) | 2014-02-03 | 2021-10-06 | Quadriga Biosciences, Inc. | Acides bêta-aminés substitués en bêta et analogues en tant qu'agents de chimiothérapie |
CN104177284B (zh) * | 2014-08-01 | 2016-08-24 | 常州大学 | 合成3-氮杂二环[3,1,0]己基-1-甲醛的方法 |
GB201506660D0 (en) | 2015-04-20 | 2015-06-03 | Cellcentric Ltd | Pharmaceutical compounds |
GB201506658D0 (en) | 2015-04-20 | 2015-06-03 | Cellcentric Ltd | Pharmaceutical compounds |
EP3299357A4 (fr) * | 2015-05-20 | 2018-11-14 | Sanwa Kagaku Kenkyusho Co., Ltd. | Cristal de sel de nouveau dérivé de 3-azabicyclo[3.1.0]hexane et son utilisation pharmaceutique |
WO2017024009A1 (fr) | 2015-08-03 | 2017-02-09 | Quadriga Biosciences, Inc. | Acides bêta-aminés substitués en bêta et analogues à utiliser en tant qu'agents de chimiothérapie et leurs utilisations |
WO2017121692A1 (fr) | 2016-01-15 | 2017-07-20 | Bayer Pharma Aktiengesellschaft | Sulfamides substitués et leur utilisation |
CA3054122A1 (fr) | 2017-03-02 | 2018-09-07 | Sanwa Kagaku Kenkyusho Co., Ltd. | Agent therapeutique pour troubles lies a la consommation d'alcool |
JP7218306B2 (ja) * | 2017-05-15 | 2023-02-06 | コグニション セラピューティクス インク. | 神経変性疾患を治療するための組成物 |
CN107501272B (zh) * | 2017-09-05 | 2020-03-31 | 中国药科大学 | 咪唑并异吲哚类ido1抑制剂、其制备方法及应用 |
CN111989327A (zh) | 2018-02-05 | 2020-11-24 | 奥克梅斯公司 | 用于治疗疼痛的化合物 |
CN112939844B (zh) * | 2019-12-10 | 2023-02-03 | 华东师范大学 | 一种多取代四氢咔唑及其衍生物及其合成方法和应用 |
CN110938036A (zh) * | 2019-12-24 | 2020-03-31 | 中国药科大学 | 一种4-碘-1h-咪唑的制备方法 |
JP2023524547A (ja) * | 2020-05-07 | 2023-06-12 | 小野薬品工業株式会社 | Kdm5阻害作用を有する3-アザビシクロ(3.1.0)ヘキサン誘導体およびその医薬用途 |
CN112300002A (zh) * | 2020-10-26 | 2021-02-02 | 安徽工业大学 | 一种5-硝基丹皮酚及5-硝基丹皮酚腙的制备方法 |
CN114057627B (zh) * | 2022-01-18 | 2022-04-01 | 南京桦冠生物技术有限公司 | 一种丙型肝炎及新冠药物中间体及其盐的制备方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB872300A (en) * | 1956-10-26 | 1961-07-05 | Wellcome Found | Improvements in and relating to new derivatives of azabicyclohexane and the manufacture thereof |
US3065230A (en) * | 1959-03-16 | 1962-11-20 | Burroughs Wellcome Co | Azabicyclohexanes and method of preparing them |
GB948730A (en) * | 1959-04-08 | 1964-02-05 | Wellcome Found | Substituted cyclopropanes and related compounds |
PH24752A (en) | 1987-04-16 | 1990-10-01 | Lilly Co Eli | Piperidine opioid antagonists |
US5159081A (en) * | 1991-03-29 | 1992-10-27 | Eli Lilly And Company | Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists |
CZ284993B6 (cs) * | 1991-03-29 | 1999-04-14 | Eli Lilly And Company | Derivát piperidinu |
DE4341403A1 (de) | 1993-12-04 | 1995-06-08 | Basf Ag | N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung |
TWI244481B (en) * | 1998-12-23 | 2005-12-01 | Pfizer | 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
-
1999
- 1999-11-16 TW TW088119947A patent/TWI244481B/zh not_active IP Right Cessation
- 1999-11-19 NZ NZ511234A patent/NZ511234A/en unknown
- 1999-11-19 IL IL14269799A patent/IL142697A0/xx unknown
- 1999-11-19 EP EP99954290A patent/EP1140828B1/fr not_active Expired - Lifetime
- 1999-11-19 PL PL99348453A patent/PL348453A1/xx not_active Application Discontinuation
- 1999-11-19 WO PCT/IB1999/001852 patent/WO2000039089A1/fr active IP Right Grant
- 1999-11-19 DK DK99954290T patent/DK1140828T3/da active
- 1999-11-19 ID IDW00200101352A patent/ID28981A/id unknown
- 1999-11-19 AT AT99954290T patent/ATE335725T1/de not_active IP Right Cessation
- 1999-11-19 CN CNB998150436A patent/CN1192021C/zh not_active Expired - Fee Related
- 1999-11-19 SK SK877-2001A patent/SK8772001A3/sk unknown
- 1999-11-19 CZ CZ20012299A patent/CZ20012299A3/cs unknown
- 1999-11-19 DE DE69932738T patent/DE69932738T2/de not_active Expired - Lifetime
- 1999-11-19 SI SI9930926T patent/SI1140828T1/sl unknown
- 1999-11-19 CA CA002356300A patent/CA2356300C/fr not_active Expired - Fee Related
- 1999-11-19 ES ES99954290T patent/ES2274646T3/es not_active Expired - Lifetime
- 1999-11-19 BR BR9916584-8A patent/BR9916584A/pt not_active Application Discontinuation
- 1999-11-19 AU AU10698/00A patent/AU761574B2/en not_active Ceased
- 1999-11-19 JP JP2000591001A patent/JP3553886B2/ja not_active Expired - Fee Related
- 1999-11-19 OA OA1200100149A patent/OA11727A/en unknown
- 1999-11-19 AP APAP/P/2001/002185A patent/AP1852A/en active
- 1999-11-19 EA EA200100417A patent/EA004672B1/ru not_active IP Right Cessation
- 1999-11-19 HU HU0104816A patent/HUP0104816A3/hu unknown
- 1999-12-08 MA MA25862A patent/MA25035A1/fr unknown
- 1999-12-08 DZ DZ990262A patent/DZ2962A1/fr active
- 1999-12-20 US US09/467,871 patent/US6313312B1/en not_active Expired - Fee Related
- 1999-12-22 UY UY25873A patent/UY25873A1/es unknown
-
2001
- 2001-04-20 IS IS5922A patent/IS2467B/is unknown
- 2001-06-22 NO NO20013148A patent/NO321658B1/no not_active IP Right Cessation
- 2001-06-25 HR HR20010477A patent/HRP20010477B1/xx not_active IP Right Cessation
- 2001-07-16 BG BG105711A patent/BG65402B1/bg unknown
- 2001-10-30 US US10/016,745 patent/US20020072616A1/en not_active Abandoned
-
2002
- 2002-05-04 HK HK02103395.3A patent/HK1041698B/zh not_active IP Right Cessation
- 2002-08-07 US US10/214,658 patent/US7049444B2/en not_active Expired - Fee Related
-
2006
- 2006-11-08 CY CY20061101604T patent/CY1106445T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO321658B1 (no) | 3-Azabicyklo[3.1.0]heksanderivater som opiatreceptorligander | |
AU2009247262B2 (en) | Amide compound | |
CA2442114C (fr) | N-(2-arylethyl)benzylamines utilisees en tant qu'antagonistes du recepteur 5-ht6 | |
ES2302839T3 (es) | Derivados de 3-azabiciclo(3.1.0)hexano como antagonistas de los receptores de opioides. | |
CA2565200A1 (fr) | Modulateurs de raf et methodes d'utilisation | |
Farr et al. | Enantiospecific and regioselective opening of 2-alkyl nosylaziridines by indoles mediated by boron trifluoride. Application to a practical synthesis of a GnRH antagonist | |
NZ523141A (en) | 3-azabicyclo (3.1.0) hexane derivatives having opioid receptor affinity | |
EP3986885B1 (fr) | Pyrrolidinamides substitués iv | |
IL142697A (en) | History 3 - Azabicyclo [0.1.3] Haxan, pharmaceutical preparations containing them, process for their preparation and use in the preparation of a drug for the treatment of diseases mediated by opiate receptors | |
MXPA01006528A (en) | 3-azabicyclo[3.1.0.]hexane derivatives as opiate receptors ligands |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |